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Abstract 
 
Background: Exercise training represents a promising approach for managing cognitive 
impairment in persons with multiple sclerosis (MS). There is preliminary evidence that treadmill 
walking exercise might be the modality of exercise that exerts the greatest beneficial effects on 
executive control in persons with mild MS disability. However, the dose-dependent effects of 
varying intensities of treadmill walking exercise on this cognitive function are unknown. Such an 
investigation is critical for providing the final data for delineating the optimal exercise stimulus 
(or stimuli) for improving executive control in persons with MS. 
 
Objectives: The present study compared the acute effects of light, moderate, and vigorous 
intensity treadmill walking exercise on multiple aspects of executive control (i.e., interference 
control and response inhibition) relative to quiet rest in 24 persons with mild MS disability, using 
a within-subjects, repeated-measures experimental design.  
 
Methods: Participants completed four experimental conditions that consisted of 20 minutes of 
light intensity treadmill walking exercise, moderate intensity treadmill walking exercise, 
vigorous intensity treadmill walking exercise, and quiet rest in a randomized, counterbalanced 
order. Participants underwent a modified-flanker task and Go/No-Go task as measures of 
executive control immediately prior to and following each condition.  
 
Results: Repeated-measures ANOVAs indicated large, statistically significant pre-to-post 
reductions in the cost of interfering stimuli on reaction time, but not accuracy, on the modified-
flanker task for light, moderate, and vigorous intensity exercise compared with quiet rest 
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(F(3,69)=4.27,p=.01,ηp
2
=.16) that were similar in magnitude. There further were no overall 
effects of exercise intensities on percent accuracy from the Go/No-Go task 
(F(3,69)=0.33,p=.81,ηp
2
=.01), compared with quiet rest.   
 
Conclusions: The present results support light, moderate, and vigorous intensity treadmill 
walking as exercise stimuli that might particularly benefit speed-related aspects of executive 
control (i.e., interference control of reaction time). This represents the final step in delineating 
the optimal exercise stimuli for inclusion in a subsequent longitudinal exercise training 
intervention for improving this cognitive function in persons with mild MS disability.  
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Chapter 1—Introduction 
 
 Multiple sclerosis (MS) can be described as a non-traumatic, immune-mediated and 
neurodegenerative disease of the central nervous system (CNS) with an estimated prevalence of 
1 per 1000 people in the United States (e.g., Wallin et al., 2000). This disease is initially 
characterized by multi-focal areas of inflammation resulting in demyelination in the CNS (Trapp 
& Nave, 2008). The disease process eventually causes irreversible damage (i.e., 
neurodegeneration) of both grey and white matter in the brain, resulting in the accumulation of 
both physical and cognitive disability. 
 Cognitive impairment is highly prevalent in MS, with upwards of 50% of patients 
demonstrating cognitive impairment based on performance on neuropsychological tests 
(Chiaravalloti & DeLuca, 2008; Benedict & Zivadinov, 2011). Such cognitive impairment 
primarily manifests as slowed cognitive processing speed, impaired learning and memory, and 
executive dysfunction, but less so as impairment in intellectual functions and language skills 
(Benedict & Zivadinov, 2011; Prakash et al., 2008). For example, one recent meta-analysis 
reported moderate-sized effects of relapsing-remitting MS (RRMS) on overall cognitive function 
(g = −0.59), as well as on the cognitive domains of attention and executive function (g = −0.56); 
there were smaller effects of RRMS on verbal functions and language deficits (g = −0.44) 
(Prakash et al., 2008). There further is meta-analytic evidence that suggests that processing 
speed, learning and memory, and executive function are even more impaired in persons with 
chronic progressive presentations of MS compared with relapsing-remitting presentations of the 
disease (Zakzanis, 2000).  
Cognitive impairment is a highly disabling consequence of MS and has been associated 
with many negative health outcomes. For example, slowed cognitive processing speed and 
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executive dysfunction have been associated with depression in MS (Bobholz & Rao, 2003; 
Arnett et al., 2001), although this relationship is not fully understood (e.g., Arnett, Barwick, & 
Beeney, 2008). Cognitive impairment and decline have further been associated with 
unemployment and loss of employment, respectively, in persons with MS (Morrow et al., 2010; 
Benedict et al., 2005), as well as the loss of driving abilities (Shawaryn et al., 2002; Lincoln & 
Radford, 2008). There is additional, longitudinal evidence that decreased performance on a 
battery of neuropsychological tests is associated with loss of independence, increased need for 
substantial assistance with activities of daily living (i.e., greater than 3 hours per day), and social 
isolation over time in persons with MS (Amato et al., 2001).  
Cognitive impairment is poorly managed in persons with MS. There is limited support for 
disease-modifying treatments (e.g., interferon-beta-1a) for mitigating cognitive impairment, and 
this is largely based on methodological concerns in several randomized controlled trials (RCTs; 
Amato et al., 2013). For example, one three-year study of patients with RRMS with mild 
disability reported that high doses of interferon-beta-1a were associated with a 32% reduction in 
risk for cognitive decline, based on neuropsychological test performance (Patti et al., 2010). 
However, an untreated control group or placebo condition was not included in the study to 
directly determine to what extent interferon-beta-1a prevented cognitive decline, thus the results 
from that study should be interpreted with caution (Patti et al., 2010). There further is equivocal 
evidence for the efficacy of symptomatic pharmacological treatments for MS-related cognitive 
impairment in general, and there are no US Food and Drug Administration (FDA)-approved 
symptomatic treatments specifically for slowed cognitive processing speed and executive 
dysfunction in this population.  
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There is conflicting evidence for the efficacy of cognitive rehabilitation interventions on 
slowed cognitive processing speed and executive dysfunction in this population (Amato et al., 
2013). One review highlighted the complete lack of cognitive rehabilitation interventions directly 
targeting slowed cognitive processing speed in MS (Amato et al., 2013). In addition, this review 
outlined the lack of convincing evidence for specific cognitive rehabilitation interventions for 
executive dysfunction in MS, though there is weak evidence that generalized cognitive training 
might improve executive functioning (Amato et al., 2013). This underscores the importance of 
considering alternative approaches for managing cognitive impairment in persons with MS. One 
such approach involves exercise training (Motl, Sandroff, & Benedict, 2011). 
 There have been three published RCTs of exercise training on cognition in persons with 
MS. The first two RCTs involved the effects of largely unsupervised yoga and aerobic exercise 
or combined aerobic and resistance exercise, respectively (Oken et al., 2004; Romberg et al., 
2005), and reported no significant intervention effects on physical fitness or cognitive function in 
persons with mild MS disability. By definition, exercise is a planned, structured, repetitive 
physical activity behavior with the goal of increasing physical fitness (Bouchard & Shephard, 
1994). Demonstrating an improvement in physical fitness is a key manipulation check for 
gauging the success of any exercise training intervention (Motl, Pilutti, & Sandroff, 2013).  
The other RCT examined the effects of a supervised, aerobic exercise training 
intervention on fitness and cognitive function in persons with progressive MS (i.e., moderate 
disability). Those who underwent cycle ergometer training demonstrated significant 
improvements in cardiorespiratory fitness and improvements in verbal memory and alertness, but 
not in cognitive processing speed or executive function, compared with a wait-list control group 
(Briken et al., 2014). The lack of an improvement in cognitive processing speed and executive 
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function from the latter RCT is partially consistent with a growing pattern of results from studies 
that suggests that physical fitness and physical activity, respectively, are associated with 
cognitive processing speed in persons with mild, but not moderate, MS disability (Sandroff, 
Pilutti, Benedict, & Motl, 2015b; Sandroff, Pilutti, Dlugonski, & Motl, 2013; Sandroff, Klaren, 
Pilutti, Dlugonski, Benedict, & Motl, 2014); those effects on executive functioning have not 
been studied. Importantly, the equivocal results from the RCTs highlight the importance of 
considering the well-established body of literature in the general population that documents 
robust, beneficial effects of exercise training on executive functioning across the lifespan (i.e., 
healthy children, young adults and older adults) (Hillman, Erickson, & Kramer, 2008). This 
approach serves as a way of better informing exercise training interventions on cognition in mild 
MS. The equivocal RCT results in MS further warrant examination of preliminary evidence of 
exercise effects on cognition in other neurological populations (McDonnell, Smith, & 
Mackintosh, 2011) to provide support for the feasibility of such a trial in MS. 
  The effects of exercise training on cognition in the general population, across the 
lifespan, have been summarized by meta-analyses on this association in healthy children, 
younger adults, and older adults, respectively. One meta-analysis reported that physical activity 
was associated with improved cognitive performance in children with an overall effect size of 
0.32 standard deviations (Sibley & Etnier, 2003). Following this meta-analysis, several well-
designed RCTs have reported that exercise training has been associated with improvements in 
executive control among children. For example, one recent RCT reported that following a 9-
month exercise intervention, 8 and 9-year old children demonstrated improvements in one aspect 
of executive control based on response accuracy on task conditions requiring the upregulation of 
inhibitory control relative to children randomized to a wait-list control condition (Chaddock-
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Heyman et al., 2013). Another noteworthy result from this study was that at follow-up, children 
who participated in the intervention demonstrated accuracy rates similar to those of young adults 
(Chaddock-Heyman et al., 2013). Exercise is associated with cognitive function in healthy 
adults, and this is further based on meta-analytic evidence (Smith et al., 2010). One such meta-
analysis reported that aerobic exercise was associated with improved attention/processing speed 
(g = 0.16) and executive function (g = 0.12) in adults over 18 years old (Smith et al., 2010). Age 
did not moderate those associations, which suggests that the beneficial effects of exercise on 
cognition were relatively equal across the span of adulthood (Smith et al., 2010). There is a large 
body of evidence that suggests that exercise is associated with cognitive function in older adults. 
One seminal meta-analysis reported that exercise training was associated with overall better 
performance on cognitive tasks in older adults with an average effect size of 0.48 standard 
deviations (Colcombe & Kramer, 2003). This meta-analysis indicated that there is a selective 
benefit of exercise training, such that the largest beneficial effects of exercise occur for executive 
control processes (g = 0.68; Colcombe & Kramer, 2003). There further is preliminary evidence 
that exercise training is associated with improvements in cognitive functioning in persons with 
neurological disorders (i.e., schizophrenia, stroke, traumatic brain injury (TBI); McDonnell et al., 
2011), though the number of RCTs in those populations is substantially smaller than in healthy 
children, younger adults, and older adults. 
The delineation of exercise stimuli for such successful interventions across the lifespan in 
the general population (and to a lesser extent in persons with neurological disorders) is, in part, 
based on examinations of the effects of acute bouts of aerobic exercise on cognitive function 
(Tomporowski, 2003; Lambourne & Tomporowski, 2010; Chang, Labban, Gapin, & Etnier, 
2012). An important assumption is that the acute effects of single bouts of exercise on cognition 
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will be additive and cumulative, much like adaptations on cardiorespiratory fitness (Haskell, 
1994), during longitudinal exercise training interventions. This increases the potential for the 
realization of meaningful improvements in cognition. The overall effects of acute exercise on 
cognitive functioning have been summarized by two recent meta-analyses (Lambourne & 
Tomporowski, 2010; Chang et al., 2012). The most recent meta-analysis reported overall modest 
effects of acute aerobic exercise on cognitive function (Cohen’s d = 0.10). Moderator analyses 
revealed larger effects for tests of executive function when administered either immediately 
following exercise (d = .19) or after a delay period following exercise (d = .17) (Chang et al., 
2012). Those effects were applicable across the lifespan, such that acute exercise was 
significantly associated with cognition in children (d = .17), younger adults (d = .07), middle-
aged adults (d = .18), and older adults (d = .18) (Chang et al., 2012). To that end, we recently 
completed a pilot study that identified a large, statistically significant pre-to-post reduction in the 
cost of interfering stimuli on reaction time (i.e., interference control of reaction time; RT) on a 
modified flanker task for an acute bout of treadmill walking exercise relative to a quiet rest 
control condition (ηp
2
 = .17) in 24 persons with mild MS disability (Sandroff, Hillman, Benedict, 
& Motl, 2015a). There were no statistically significant pre-to-post reductions in interference 
control of RT on the modified flanker task for cycle ergometry or yoga relative to quiet rest; 
there further were no effects identified for any of the conditions for cognitive processing speed, 
based on Symbol Digit Modalities Test (SDMT) scores, perhaps due to carry-over effects 
(Sandroff et al., 2015a).  
The results from that pilot study suggest that treadmill walking is the modality of exercise 
that might exert the largest beneficial effects of exercise on executive control in persons with 
mild MS disability. However, prior to developing a RCT on the effects of chronic treadmill 
7 
 
walking exercise on executive control in mild MS, it is necessary to examine the dose-dependent 
effects of varying intensities of treadmill walking exercise on executive control in this 
population. Such an endeavor would then identify the optimal exercise stimulus (i.e., modality 
and intensity) for inclusion in a well-designed clinical trial of exercise training and cognition in 
mild MS. This would maximize the potential for persons with MS to demonstrate meaningful 
improvements in executive control, as presumably, the acute effects of treadmill walking 
exercise on executive control will be additive and cumulative when the optimal intensity of 
treadmill walking exercise is included as the primary stimulus in a longitudinal training study. 
The current study involved the examination of the effects of twenty-minute bouts of light, 
moderate, and vigorous intensity treadmill walking exercise compared with a quiet rest control 
condition on executive control in persons with MS. Based on previous research using modified 
flanker and Go/No-Go paradigms in healthy control subjects (Pontifex, Saliba, Raine, 
Picchhietti, & Hillman, 2013; Gothe, Pontifex, Hillman, & McAuley, 2013; Kamijo et al., 2004; 
Drollette, Shishido, Pontifex, & Hillman, 2012), the primary hypothesis was that walking at a 
moderate intensity would exert the strongest acute effects on executive control compared with 
light and vigorous intensity walking, respectively, relative to quiet rest. The secondary 
hypothesis was that those effects would be larger in cognitive tasks requiring greater levels of 
executive control. If successful, this line of research will ultimately provide clinicians and 
patients with better guidelines for using chronic exercise training as an approach for the 
management of cognitive impairment as a highly prevalent, poorly-managed, and life-altering 
symptom of MS. 
  
8 
 
Chapter 2—Review of Literature 
OVERVIEW 
 The current review of literature provides critical information for developing the rationale 
for the design of the present study of the acute effects of varying intensities of treadmill walking 
exercise on cognition in persons with MS. This chapter first describes the epidemiology of MS 
(i.e., incidence, prevalence, genetic/environmental risk factors), followed by a brief section on 
the clinical course of the disease along with the pathophysiological mechanisms that manifest as 
physical and cognitive disability. This chapter then discusses the highly-prevalent and disabling 
nature of cognitive dysfunction in MS as well as the body of equivocal evidence for 
pharmacological and non-pharmacological approaches for managing cognitive dysfunction in 
this population. Based on the conflicting evidence for those approaches, this chapter then 
reviews research examining exercise training as an alternative approach for managing this 
prevalent and disabling feature of MS. As the research on exercise and cognition in MS is in its 
infancy, the current chapter discusses results from studies of the effects of chronic exercise 
training and acute bouts of exercise, respectively, on cognitive functioning in other populations. 
This serves as a backdrop for better informing studies of exercise and cognition in MS. This 
chapter then concludes with a brief summary of the rationale and experimental design of the 
current study, within the context of the previously described research in persons with MS and 
other populations. 
 
EPIDEMIOLOGY OF MS 
MS can be described as a non-traumatic, immune-mediated and neurodegenerative 
disease of the CNS that typically presents in the 3
rd
 or 4
th
 decade of life (Wallin, Page, & 
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Kurtzke, 2000; Mayr, Pittock, McClelland, Jorgensen, Noseworthy, & Rodriguez, 2003). As of 
the year 2000, median age of diagnosis was reported to be 37.2 years (Mayr et al., 2003), and 
median survival has been reported to be between 30-43 years following diagnosis (Wallin et al., 
2000).  In terms of sex differences, women are affected nearly three times more often than men 
(Noonan, Kathman, & White, 2002). Global incidence of MS peaks at about 30 years of age 
(Koch-Henriksen & Sorenson, 2010), and raw incidence rates have been reported to range from 
0.86 per 100,000 person-years to 12.2 per 100,000 person-years (Mayr et al., 2003).   
MS is among the most common neurological diseases worldwide, with a global 
prevalence thought to exceed 2 million cases (Kingwell et al., 2013). Based on a systematic 
review of epidemiological studies across the globe (Koch-Henriksen & Sorenson, 2010), MS has 
been reported to have the highest prevalence estimates in Western Europe and North America, 
followed by areas in Central and Eastern Europe, the Balkans, and Australia/New Zealand.  
Regions with the lowest prevalence estimates included Asia, the Middle East, and Africa (Koch-
Henriksen & Sorenson, 2010). Accordingly, MS is more common in individuals with Northern 
European ancestry than those of Hispanic, African, or Asian descent (Williamson, Henry, 
Schiffer, & Wagner, 2007; Mayr et al., 2003). In the United States, MS has an estimated 
prevalence of 1 per 1000 people (Wallin et al., 2000; Mayr et al., 2003; Koch-Henriksen & 
Sorenson, 2010; Williamson et al., 2007; Noonan, Kathman, & White, 2002). Within the United 
States, geographically, MS is most prevalent in the northern states and less so in southern states 
(Wallin et al., 2000; Williamson et al., 2007). 
To date, a singular cause of MS has not been identified, though there is support for both 
genetic and environmental risk factors. Despite MS not being typified as a genetic disorder with 
a single major locus (e.g., Huntington’s Disease), there is evidence to suggest a maternal parent-
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of-origin effect in MS, and that MS is linked with HLA genes (Ramagopalan, Dobson, Meier, & 
Givoannoni, 2010). Epidemiological data further support environmental risk factors for MS. To 
that end, one recent review highlighted Epstein-Barr virus (EBV) infection, smoking, and 
Vitamin D deficiency as contributing risk factors for the disease (Ramagopalan et al., 2010). 
Infection with EBV and subsequent diagnosis of mononucleosis is associated with an increased 
risk of MS. Studies have reported that approximately 99% of persons with MS have previously 
been infected with EBV (e.g., Ascherio & Munger, 2007), whereas 94% of healthy controls have 
previously been infected (Ramagopalan et al., 2010). This suggests that EBV infection is not 
specific to MS, although there further seems to be an increased risk of MS if infected with EBV 
during adulthood compared with childhood EBV infection (Ascherio & Munger, 2007).  
Smoking has also been identified as a risk factor for MS. One meta-analysis reported a 
1.51 pooled odds ratio of MS diagnosis for smokers versus non-smokers (Hawkes, 2007); there 
further seems to be a dose-response effect among smokers such that a greater volume of smoking 
(e.g., smoking more cigarettes) is associated with a substantially larger risk for MS (Hawkes, 
2007). Although EBV infection and smoking represent potential environmental risk factors, there 
is a considerably larger body of literature examining Vitamin D deficiency as a risk factor for 
MS.  
Globally, there is a trend for increased prevalence of MS in temperate climates, 
particularly with increasing latitude (i.e., increasing distance from the Equator) (Koch-Henriksen 
& Sorenson., 2010; Ramagopalan et al., 2010), where there is a general lack of sunlight 
exposure. Reviews and meta-analyses have identified Vitamin D as a potential mediator of the 
association between latitude/sunlight exposure and MS prevalence (Ascherio, Munger, & Simon, 
2010; Ramagoplan et al., 2010), and have further identified Vitamin D to have an independent, 
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protective effect against MS (Ascherio et al., 2010). However, one limitation to the Vitamin D 
hypothesis is that the proposed mechanisms of its protective effect against MS are not well-
understood. 
 
CLINICAL DISEASE COURSE AND UNDERLYING PATHOPHYSIOLOGY OF MS 
MS was first recognized and popularized as a progressive neurologic disease involving 
multiple lesions of variable size and distribution throughout the CNS by Charcot in 1868 
(Hickey, 1999). Over the past 147 years, there have been many descriptions of the clinical course 
and underlying pathophysiological mechanisms of MS that have been continually revised and 
refined with advancements in technology and research methodology. The current section 
presents a brief review of the presently accepted views on the clinical course and 
pathophysiological mechanisms of MS. 
Prior to a definite diagnosis of MS, a majority of patients experience clinically isolated 
syndrome (CIS) (Miller, Chard, & Ciccarelli, 2012). CIS is defined as the first clinical episode in 
which a patient demonstrates signs and symptoms that might be suggestive of an inflammatory, 
demyelinating CNS disease (e.g., MS). Approximately 30-70% of CIS cases result in an eventual 
MS diagnosis (Miller et al., 2012). There are relapsing and progressive presentations of MS.  
Approximately 85% of patients experience a clinical disease course consisting of periodic 
neurological exacerbations, or relapses, followed by periods of relatively stable neurological 
function. This biphasic pattern is termed relapsing-remitting multiple sclerosis (RRMS) (Trapp 
& Nave, 2008; Smith & McDonald, 1999; Vollmer, 2007; Mitchell, Benito-Leon, Morales 
Gonzales, Rivera-Navarro, 2005). These relapses are attributed to instances of acute 
inflammation (i.e., acute demyelinating lesions) in the CNS, which cause damage to myelinated 
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axons and neurons (Vollmer, 2007), subsequently hindering neuronal conduction. There is not a 
1:1 ratio of lesions to relapses; rather, the number of demyelinating brain lesions seems to 
outnumber the number of relapses 10:1, which suggests that that MS might have underlying 
pathology that is clinically silent (Trapp & Nave, 2008). Although axonal loss is highly prevalent 
in acute inflammatory demyelinating MS lesions, acute lesions are not strongly associated with 
permanent disability.  
In the period following this acute inflammation (i.e., remission phase), growth factors 
promote remyelination of damaged axons in the CNS (Vollmer, 2007; Smith & McDonald, 
1999). Those axons undergoing remyelination can regain the ability to conduct, albeit often in a 
diminished capacity. Over time, the ability for growth factors to remyelinate damaged axons 
following a relapse decreases, leading to neuronal degeneration and eventual irreversible 
neurological disability (Vollmer, 2007). After a period of 8-20 years, a majority of persons with 
RRMS experience a new disease course consisting of irreversible neurological impairment, 
without relapses, termed secondary progressive MS (SPMS) (Trapp & Nave, 2008; Smith & 
McDonald, 1999; Vollmer, 2007). Additionally, 15% of individuals diagnosed with MS have a 
disease course that presents with immediate irreversible neurological damage, termed primary 
progressive MS (PPMS) (Trapp & Nave, 2008; Smith & McDonald, 1999). PPMS is generally 
later onset than RRMS, and both progressive disease courses have been linked to axonal 
degeneration (Trapp & Nave, 2008; Smith & McDonald, 1999).   
Axonal degradation, which is initially triggered by chronic demyelination associated with 
progressive MS, leads to irreversible neurological disability (Confavreux & Vukusic, 2006; 
2014; Vollmer, 2007; Trapp & Nave, 2008; Smith & McDonald, 1999). During progressive 
presentations of MS, the CNS can no longer compensate for additional neuronal loss, such that 
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brain atrophy occurs in the absence of new inflammatory demyelinating lesions. This suggests 
that mechanisms other than inflammatory demyelination are responsible for irreversible 
neurologic impairment (Trapp & Nave, 2008; Confavreux & Vukusic, 2006; 2014). Two 
mechanisms have been proposed to explain how axonal degeneration occurs in MS. The first 
mechanism involves axonal degeneration following chronic demyelination due to inadequate 
trophic support, provided by oligodendrocytes (Trapp & Nave, 2008). The other proposed 
mechanism for this degenerative process is that following chronic demyelination, axons 
degenerate due to increases in intracellular calcium (Ca
2+
), which eventually leads to axonal loss 
(Trapp & Nave, 2008).  
A key issue regarding the underlying pathophysiological mechanisms involves the shift 
from immune-mediated, inflammatory disease processes to largely neurodegenerative disease 
processes. As such, a major goal of treatment is to prevent relapses (i.e., limit chronic 
demyelination) in order to delay the progression from inflammation to neurodegeneration 
(Vollmer, 2007). Disease-modifying treatments (DMTs) (e.g., Interferon-beta-1a/b) have been 
approved by the FDA for the prevention of relapses, though such therapies are not effective for 
reducing brain atrophy (i.e., reducing neurodegeneration) during the progressive stage of MS 
(Confavreux & Vukusic, 2006; PRISMS Study Group, 1998). Recent studies have identified 
prominent areas of MS-related neurodegeneration in the brain (i.e., cortical atrophy) that include 
the cingulate gyrus, and insular, frontal, temporal, and parietal cortices, with less degeneration 
occurring in the primary motor, sensory, and visual cortices (Trapp & Nave, 2008). Those areas 
of MS-related cortical atrophy have further been linked with cognitive impairment (Benedict & 
Zivadinov, 2011).   
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COGNITIVE DYSFUNCTION IN MS: PREVALENCE, DOMAINS, AND IMPACT 
Prevalence of Cognitive Dysfunction in MS 
Cognitive impairment is common and debilitating in MS. Based on a review of studies 
involving neuropsychological testing, an estimated 45-65% of individuals with MS demonstrate 
cognitive impairment (Benedict & Zivadinov, 2011). Another review highlighted that overall, 
cross-sectional studies that have been performed in clinical settings have previously estimated 
that 54-65% of persons with MS are cognitively impaired, whereas community-based studies 
have reported lower prevalence estimates of cognitive impairment (i.e., 43-46%; Amato, 
Portaccio, & Zipoli, 2006a). The prevalence of cognitive impairment might vary based on 
clinical presentation of MS (Amato et al., 2006a; Benedict & Zivadinov, 2011). Cognitive 
dysfunction is prevalent in the three main clinical disease courses (e.g., RRMS, SPMS, and 
PPMS), and can often affect individuals in the earliest stages of the disease, even prior to a 
definite MS diagnosis (i.e., CIS) (Amato et al., 2006a; Denney, Sworowski, & Lynch, 2005; 
Achiron & Barak, 2006). One recent study reported that approximately 35% of patients with 
RRMS are cognitively impaired, based on scores at least 1 standard deviation below the 
normative value on two separate neuropsychological tests (Patti et al., 2009). However, other 
large studies have reported that approximately 60% of samples that included both persons with 
relapsing and progressive presentations of MS demonstrated cognitive impairment, based on 
poor performance on neuropsychological tests (e.g., Benedict et al., 2006b). Other research 
suggests that although cognitive impairment can occur in CIS (i.e., greater impairment than 
healthy controls), the prevalence of cognitive impairment is considerably lower than in those 
with RRMS and SPSMS (Potagas et al., 2008).   
Domains of Cognitive Dysfunction in MS 
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Reviews and meta-analyses have documented that cognitive dysfunction in MS, 
measured by neuropsychological testing, typically presents as slowed cognitive processing 
speed, executive dysfunction, and impairments in learning and memory; intellectual functions 
and language skills are relatively spared (Benedict & Zivadinov, 2011; Bobholz & Rao, 2003; 
Zakzanis, 2000; Prakash, Snook, Lewis, Motl, & Kramer, 2008). One review described these 
impairments relative to healthy controls across a variety of methodological paradigms for 
assessing cognitive function, and further summarized that in general, persons with progressive 
presentations of MS performed worse on neuropsychological tests of cognitive processing speed, 
executive function, and learning and memory than persons with RRMS (Bobholz & Rao, 2003). 
Three meta-analyses have examined the effects of MS on cognitive function. An early 
meta-analysis described impairments of similar magnitude in multiple cognitive domains (i.e., 
general cognitive ability, learning and memory, interhemispheric transfer) across studies of 
persons with MS (Wishart & Sharpe, 1997). Interestingly, in this quantitative review, disease 
course was not a significant moderator of the association between MS and domains of cognitive 
function (Wishart & Sharpe, 1997). A later meta-analysis of cognitive function and MS 
examined 34 studies, and included a pooled sample of 1,845 persons with MS and 1,265 healthy 
controls (Zakzanis, 2000). This meta-analysis reported large, negative effects of MS on cognitive 
processing speed based on SDMT scores (d = −1.36) and learning and memory based on scores 
from the delayed recall portion of the Selective Reminding Task (SRT) (d = −1.44), as well as 
moderate, negative effects on executive function based on performance on the Stroop Color-
Word Interference Test (d = −0.62) (Zakzanis, 2000). The moderator analysis from this study 
was not consistent with the results of the previous meta-analysis (Wishart & Sharpe, 1997) such 
that the impact of slowed processing speed and executive dysfunction was greater in persons 
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with chronic progressive presentations of MS compared with relapsing-remitting presentations of 
the disease (Zakzanis, 2000). A third, more recent meta-analysis examined cognitive 
impairments in individuals with RRMS (Prakash et al., 2008). This meta-analysis examined 57 
studies that yielded 755 total effects. Overall, diagnosis of RRMS had a negative effect of 
moderate magnitude on cognition (g = −0.59) (Prakash et al., 2008). The moderator analysis 
revealed that RRMS had larger, negative effects on the domains of learning and memory (g = 
−0.61) and executive function/attention (namely cognitive processing speed; g = −0.56) than on 
the domains of verbal functioning and language (g = −0.44) and concept formation and reasoning 
(g = −0.31) (Prakash et al., 2008). Those core cognitive deficits, including impairments in 
inhibitory control (i.e., an executive function of interest), have further been associated with 
cortical atrophy and other structural brain outcomes (e.g., Benedict et al., 2006a; 2013; Genova 
et al., 2013, Benedict, Bakshi, Simon, Priore, Miller, & Munschauer, 2002; Bagnato et al., 2010; 
Penner, Rausch, Kappos, Opwis, & Radü, 2003).  
Impact of Cognitive Dysfunction in MS 
  Cognitive impairment is a highly disabling consequence of MS. There is evidence that 
cognitive impairment has been linked with depression in MS, although this relationship is not 
fully understood (Arnett et al., 2008). There is some evidence describing associations between 
slowed cognitive processing speed and executive dysfunction and depression in MS (Rao, Leo, 
Ellington, Nauertz, Bernardin, & Unverzagt, 1991; Arnett, Higginson, & Randolph, 2001). For 
example, one longitudinal study reported that processing speed and executive function, based on 
scores from the Tower of London test, independently predicted 33% of variance in depression 
scores in 79 persons with MS (Arnett et al., 2001).  
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Further, cognitive impairment and decline have been associated with unemployment and 
loss of employment, respectively, in persons with MS (Morrow, Drake, Zivadinov, Munschauer, 
Weinstock-Guttman, & Benedict, 2010; Benedict et al., 2005). One recent longitudinal study 
followed 65 newly-diagnosed persons with MS over a 7-year period, and reported that at 
baseline, approximately 82% of the sample was employed, and at follow-up 7 years later, only 
54% of the sample was employed (Ruet et al., 2012). Of those who were not working at follow-
up, nearly 80% of participants were cognitively impaired based on neuropsychological test 
performance (Ruet et al., 2012). To that end, another study established a minimal clinically 
important difference (MCID) score of 4 on the SDMT as being predictive of employment status 
in persons with MS (Morrow et al., 2010). 
There is further evidence that cognitive impairment in MS is associated with the loss of 
driving ability (e.g., Shawaryn, Schultheis, Garay, & DeLuca, 2002; Lincoln & Radford, 2008). 
One exemplar cross-sectional study of 34 persons with MS reported that tests of cognitive 
processing speed, executive function, and visual memory, in particular, predicted safety to drive, 
based on performance on a road test (Lincoln & Radford, 2008).  
Finally, MS-related cognitive impairment is associated with loss of independence, 
increased reliance on caregivers, and social isolation. One seminal longitudinal study examined 
neuropsychological performance and the effects on everyday functioning in 45 persons with MS 
over a 10-year period (Amato, Ponziani, Siracusa, & Sorbi, 2001). Importantly, over time, 
decreased performance on a battery of neuropsychological tests, independent of physical 
disability, predicted loss of independence, increased need for substantial assistance with 
activities of daily living (i.e., greater than 3 hours per day), and extent of social isolation in 
persons with MS (Amato et al., 2001).  
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TREATMENT OF COGNITIVE DYSFUNCTION IN MS 
Strategies for specifically treating cognitive impairment in MS can be classified based on 
two approaches: pharmacological and non-pharmacological (Amato et al., 2013). This section of 
the review first discusses the evidence regarding pharmacological approaches for managing 
cognitive impairment in MS, based on disease modifying therapies (DMTs) and symptomatic 
treatments. This section then discusses the evidence describing the effects of non-
pharmacological approaches (i.e., cognitive rehabilitation) for managing cognitive impairment in 
MS. 
Pharmacological Approaches 
DMTs. Currently, there is no FDA-approved pharmacological treatment for cognitive 
dysfunction in MS (Amato et al., 2013). Disease-modifying agents (e.g., interferon beta-1a, 
interferon beta-1b, glatiramer acetate, and natalizumab) reduce ongoing CNS inflammatory 
activity associated with MS pathophysiology, and are hypothesized to reduce cognitive 
impairment based on this mechanism (Amato et al., 2013). However, overall results from studies 
linking DMTs to performance on neuropsychological tests have been disappointing, primarily 
due to methodological limitations, resulting in poor internal validity (Amato et al., 2006a; 
Amato, Zipoli, & Portaccio, 2006b; Amato et al., 2013). For example, one three-year study of 
patients with RRMS with mild disability reported that high doses of interferon-beta-1a were 
associated with a 32% reduction in risk for cognitive decline, based on neuropsychological test 
performance (Patti et al., 2010). One methodological issue with that study is that there was not 
an untreated control group or placebo condition to directly quantify the extent to which 
interferon-beta-1a prevented cognitive decline (Patti et al., 2010).  
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Another open-label, non-randomized, non-placebo controlled study examined the effects 
of interferon β-1b on cognitive function compared with a non-treatment control (i.e., passive 
control) (Barak & Achiron, 2002). After 1 year, patients treated with interferon β-1b 
demonstrated improved performance on cognitive tests of attention and visuospatial learning; 
but, there were no treatment effects of the interferon on cognitive processing speed, based on 
SDMT performance, relative to those in the untreated control condition (Barak & Achiron, 
2002). This null result was particularly disappointing given that slowed cognitive processing 
speed is the most common cognitive impairment among persons with MS, and the SDMT is 
widely recognized as the most sensitive neuropsychological test of cognitive processing speed in 
MS (Benedict & Zivadinov, 2011). 
The effects of glatiramer acetate (GA) on cognitive function have also been examined in 
a Phase III clinical trial (Weinstein, Schwid, Schiffer, McDermott, Giang, & Goodman, 1999). 
Two hundred forty-eight patients initially underwent Rao’s Brief Repeatable Battery (BRB) of 
neuropsychological tests, and were treated with either GA or placebo for 2 years; cognitive 
testing further was administered at the 12 and 24-month time points, respectively. There were no 
significant differences in neuropsychological performance between groups at baseline. Both 
groups demonstrated improvements in cognition overall (i.e., non-significant group × time 
interactions) at both the 12- and 24-month time points, though the GA group did demonstrate a 
reduction in disease activity (Weinstein et al., 1999). A recent review suggested that the null 
results on cognition from the above study might be due to a ceiling effect, based on the sample 
not demonstrating cognitive impairment at baseline (Amato et al., 2013).  
Finally, the effects of natalizumab on cognitive function have not been well-studied in 
persons with MS. Although there have not been definitive results from Phase III RCTs of 
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natalizumab on cognitive function in MS, there have been preliminary studies that suggest 
promising effects of this DMT on cognition (e.g., Portaccio et al., 2013; Mattioli, Stampatori, & 
Capra, 2011). 
Symptomatic Treatments. Pharmacological symptomatic treatments (e.g., L-amphetamine 
sulfate, modafinil, and donepezil) have been considered as a means to improve cognitive 
function in individuals with MS to mixed results. L-amphetamine sulfate (i.e., a CNS stimulant) 
has been associated with enhanced memory in both animal models and humans (Morrow et al., 
2009). There further is preliminary evidence to suggest that L-amphetamine sulfate might 
enhance cognitive processing speed in MS, based on promising findings from a within-subjects 
trial involving 19 persons with MS (Benedict et al., 2008). However, those results were not 
replicated in a randomized, double-blind, placebo-controlled trial of 151 cognitively impaired 
persons with MS (Morrow et al., 2009). In that study, participants received either a 29-day oral 
dose of 30 mg of L-amphetamine sulfate or placebo, and a battery of neuropsychological tests 
was administered both before and after the 29-day treatment period for both groups. 
Disappointingly, results indicated that there were no significant improvements on cognitive 
processing speed, based on SDMT performance (Morrow et al., 2009).   
Modafinil is another potential symptomatic treatment for cognitive impairment in MS, 
and is a CNS stimulant that was originally designed as an anti-fatigue agent. To date, there is not 
convincing evidence for its enhancement of cognitive function in MS (Amato et al., 2013; 
Lovera et al., 2010). For example, one recent double-blind, placebo-controlled RCT examined 
the effects of a daily 200 mg dose of modafinil (or placebo) for 8 weeks on cognitive processing 
speed in 121 persons with MS (Mӧller et al., 2011). There was a significant positive effect of 
modafinil on SDMT scores relative to the placebo, but not on Paced Auditory Serial Addition 
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Test (PASAT) scores (i.e., another measure of cognitive processing speed), which actually 
improved in the placebo group over the 8-week period (Mӧller et al., 2011).  
Donepezil, an acetylcholinesterase inhibitor used to treat dementia in individuals with 
Alzheimer’s disease, has been considered as a potential treatment of cognitive impairment in 
MS. In a randomized, double-blind, placebo-controlled study, the effectiveness of donepezil on 
memory function was evaluated in a sample of 69 individuals with MS (Christodoulou, Melville, 
Scherl, MacAllister, Elkins, & Krupp, 2006). Participants received treatment for 24 weeks with 
either donepezil or a placebo and completed the SRT at both baseline and at the completion of 
the treatment course (Christodoulou et al., 2006). Results indicated that patients receiving 
donepezil significantly improved memory function to a medium effect size compared with the 
placebo group (Christodoulou et al., 2006). However, a recent multi-center double-blind, 
placebo-controlled RCT did not replicate those results, such that there was not a significant 
effect of donepezil on SRT performance (Krupp et al., 2011).  
The generally equivocal results from studies examining L-amphetamine sulfate, 
modafinil, and donepezil might be due to methodological limitations. Perhaps those studies did 
not include the optimal neuropsychological outcome measure based on each drug’s biological 
mechanism for evaluating the effectiveness of those treatments. Another plausible explanation is 
that those studies might not have optimized the dosage of each treatment for maximal effects on 
cognitive functioning. A third potential explanation might involve selection biases, as the 
effectiveness of those treatments might depend on level of cognitive impairment (Amato et al., 
2013). Clearly, more research on symptomatic pharmacological treatments of cognitive 
impairment in MS is needed with stronger experimental designs involving larger sample sizes 
(Amato et al., 2006b; 2013).   
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Non-Pharmacological Approaches 
Non-pharmacological treatment of cognitive impairment in MS primarily involves 
cognitive rehabilitation. Cognitive rehabilitation interventions are designed to either directly 
improve cognition or develop strategies to compensate for cognitive impairment, and can often 
include psychotherapy for addressing issues that can indirectly affect cognitive impairment (e.g., 
depression, personality difficulties; Amato et al., 2013; Bobholz & Rao, 2003; Chiaravalloti & 
DeLuca, 2008). In general, results from studies examining the effectiveness of cognitive 
rehabilitation in persons with MS have been largely disappointing, due to small sample sizes and 
methodological flaws (O’Brien, Chiaravalloti, Goverover, & DeLuca, 2008; Chiaravalloti & 
DeLuca, 2008). However, there are recent data that seemingly support cognitive rehabilitation 
interventions in persons with MS (Amato et al., 2013). Though this line of research is in its 
infancy, there have been several studies and reviews examining the effects of cognitive 
rehabilitation on specific cognitive domains. 
The vast majority of successful cognitive rehabilitation interventions in MS have focused 
on learning and memory. One promising double-blind, placebo-controlled RCT examined the 
effect of a 5-week cognitive rehabilitation training program on memory in 29 persons with MS. 
This training program involved the use of imagery and context to aid new learning 
(Chiaravalloti, DeLuca, Moore, & Ricker, 2005). Those who were randomly assigned to the 
training program demonstrated improvements in memory based on self-report and performance 
on neuropsychological tests relative to those who underwent the placebo condition (i.e., non-
specific memory exercises; Chiaravalloti et al., 2005). Further, a recent study replicated this 
intervention in 8 persons with MS and reported that persons who underwent imagery and context 
training demonstrated significantly increased blood oxygen level dependent activation of frontal 
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and parahippocampal brain regions during a functional MRI (fMRI) memory task compared with 
those who underwent the placebo training condition (Chiaravalloti, Wylie, Leavitt, & DeLuca., 
2012). 
The evidence supporting cognitive rehabilitation interventions for improving cognitive 
processing speed and executive functioning in MS is far less convincing than for learning and 
memory (Amato et al., 2013). In fact, there are no published cognitive rehabilitation 
interventions for specifically improving cognitive processing speed, as highlighted by one recent 
review (Amato et al., 2013). There further is equivocal evidence supporting cognitive 
rehabilitation interventions for improving executive functioning. This is largely based on the lack 
of definitive evidence for targeted executive function training interventions for specifically 
improving executive functioning in persons with MS. However, there seems to be more 
convincing support for generalized cognitive rehabilitation on executive functioning in this 
population (Amato et al., 2013). One double-blind, controlled study examined the effects of a 3-
day per week generalized computerized training program on executive function over a 3 month 
period in 20 persons with MS (Mattioli, Stampatori, Zanotti, Parrinello, & Capra, 2010). This 
study reported improvements in executive function, based on PASAT and Wisconsin Card 
Sorting Task scores for the intervention group, compared with an untreated control condition 
(Mattioli et al., 2010).    
Collectively, there is some evidence to support pharmacologic and non-pharmacologic 
treatments for mitigating cognitive impairment in MS; however, there is not yet overwhelming 
support for either approach (Amato et al., 2013). This highlights the need for examining 
alternative behavioral approaches for managing cognitive dysfunction in persons with MS. One 
such approach involves exercise training. 
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EXERCISE TRAINING AND COGNITION IN MS 
Exercise training might represent a behavioral approach for managing cognitive 
dysfunction in persons with MS, but this area has been understudied. There is emerging interest 
by researchers and clinicians in the effects of exercise (i.e., planned behavior aimed towards 
improving an individual’s fitness), fitness (i.e., characteristics of an individual, reflecting aerobic 
capacity, muscular strength, balance, body composition, etc.) and physical activity (i.e., skeletal 
muscle contraction resulting in increased energy expenditure) on cognition in individuals with 
MS. To that end, this section of the review provides a brief history of the evidence of exercise 
training, fitness, and physical activity effects on cognitive function in MS, based on publication 
date. This brief history provides critical background information for the development of a line of 
research on exercise training and cognition in MS (e.g., Motl et al., 2011) that includes the 
current study. 
Two initial RCTs examined the effects of exercise training on cognition in persons with 
MS. The first RCT involved a six-month intervention consisting of a weekly yoga class, weekly 
aerobic exercise class, or wait-list control condition in 57 individuals with mild MS disability 
(mean Expanded Disability Status Scale (EDSS) score = 2.9; Oken et al., 2004). Participants 
were randomized to the yoga, aerobic exercise, or control group. The yoga intervention consisted 
of a 90-minute session of Iyengar yoga, adapted for persons with MS, taking place once per 
week. The aerobic exercise intervention entailed group exercise on a stationary bicycle at the 
intensity of 2-3 on the Borg Rating of Perceived Exertion (RPE) scale (i.e., minimal exertion); 
sessions took place once per week, and home exercise was encouraged (Oken et al., 2004). 
Periodically, participants were given the option of exercising on a Swiss ball rather than cycling. 
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Cognition was measured prior to and following the six-month period using a battery of 
neuropsychological tests that mainly captured various aspects of attention, cognitive processing 
speed, and executive function. Following the completion of the intervention, neither the yoga 
group nor the exercise group demonstrated significant improvements in any cognitive measure 
(e.g., Stroop Color-Word Interference Test, PASAT) compared with the wait-list control group 
(Oken et al., 2004).   
Importantly, there are some methodological concerns with that study. One concern is that 
the aerobic exercise intervention was conducted at an extremely light intensity (e.g., 2-3 on the 
Borg RPE scale) as well as occurring only once per week, such that the maximal benefits of 
exercise training on cognition could not be realized. In fact, the aerobic exercise stimulus was 
not frequent nor intense enough to meet public health guidelines for accruing general health 
benefits (i.e., resulting in less than 150 minutes of moderate-to-vigorous physical activity per 
week) (American College of Sports Medicine (ACSM), 2013). Participation in the weekly 
classes of either experimental condition was quite low (65%), further curtailing the potentially 
beneficial effects of aerobic exercise or yoga on cognition in persons with MS.  Moreover, the 
home exercise that was encouraged to participants was unsupervised, potentially compromising 
the possible benefits of the aerobic exercise intervention on cognition. This methodological 
concern was compounded by the absence of an intervention effect on physical fitness. Physical 
fitness is a key manipulation check for gauging the success of any exercise training intervention 
(e.g., Motl et al., 2013), and this lack of a manipulation check further brings into question the 
effectiveness of the exercise stimuli for optimally benefitting cognitive function in MS.  
The other early RCT of exercise training on cognition in MS involved 95 persons with 
mild MS disability (median EDSS = 2.0) who were randomized into either a six-month long 
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exercise training intervention or wait-list control group (Romberg, Virtanen, & Ruutiainen, 
2005). The exercise training intervention consisted of five resistance training sessions and five 
aerobic training sessions in the first 3 weeks of the intervention, followed by 23 weeks of a 
prescribed home exercise regimen (Romberg et al., 2005). This part of the program, prescribed 
by physiotherapists, entailed mostly resistance exercise (i.e., suggested to take place 3-4 times 
per week) with additional sessions of aerobic exercise (i.e., suggested to take place once per 
week) (Romberg et al., 2005). Participants were encouraged via phone to adhere to the home 
exercise program on four separate occasions over the six-month intervention (Romberg et al., 
2005). Cognition was measured prior to and following the six-month period using only the 
PASAT. Accordingly, cognitive processing speed did not significantly improve in persons with 
MS who underwent the exercise intervention (Romberg et al., 2005).   
One similar concern about the results of this RCT is that physical function did not 
significantly improve in the exercise group over the six-month period (ES = −0.19), indicating 
that the exercise prescription was ineffective (Romberg et al., 2005). Additionally, physical 
function was assessed through a self-reported measure of quality of life (MSQOL-54), rather 
than with an objective performance measure (i.e., aerobic capacity). Given that this exercise 
stimulus largely consisted of resistance training, a major study limitation is that there was no 
measure of muscular strength that was administered prior to and following the intervention. A 
possible factor for the lack of improvement of physical function (and possibly cognitive 
processing speed) was the under-regulation of the exercise training program from weeks 4-26 
(i.e., only four instances of contact between physiotherapists and participants during a 23-week 
long intervention).  
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As results from the first two RCTs of exercise training on cognition in MS were 
disappointing, perhaps due to methodological concerns, several studies then examined the cross-
sectional effects of physical fitness (a presumed surrogate for exercise training) on cognition 
(i.e., primarily cognitive processing speed) in MS to better inform subsequent RCTs. The first 
cross-sectional study examined the association between cardiorespiratory fitness (i.e., aerobic 
capacity) and cognition, as well as cortical activation patterns using fMRI in 24 individuals with 
mild MS disability (mean EDSS = 2.6; Prakash et al., 2007). Cardiorespiratory fitness was 
assessed using an incremental exercise test to exhaustion on a cycle ergometer in order to 
measure aerobic capacity, based on peak oxygen consumption (VO2peak) (Prakash et al., 2007). 
Cognition was assessed using Rao’s BRB (i.e., SRT, Spatial Recall Test, PASAT, SDMT, and a 
word-list generation task), as well as with the PVSAT, a fMRI paradigm that is based on the 
PASAT (Prakash et al., 2007). Results indicated that greater aerobic capacity was significantly 
correlated with shorter RT on the PVSAT and higher scores on the PASAT, but not scores on 
measures of learning and memory (i.e., SRT) (Prakash et al., 2007). Additionally, higher aerobic 
capacity was associated with greater activation of the right inferior frontal gyrus and middle 
frontal gyrus, and less activation of the anterior cingulate cortex during the PVSAT (Prakash et 
al., 2007). This pattern of neural activation in persons with MS is similar to the pattern of 
activation observed during successful completion of an executive control task in high fit older 
adults and healthy young adults (Colcombe et al., 2004).   
A later cross-sectional study examined the relationship between aerobic capacity, white 
and grey matter integrity, and cognition in a sample of 21 persons with mild MS disability (mean 
EDSS = 2.2) and 15 healthy controls (Prakash, Snook, Motl, & Kramer, 2010). All participants 
underwent an incremental exercise test to exhaustion on a cycle ergometer for measurement of 
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aerobic capacity (i.e., VO2peak). Participants also underwent Rao’s BRB of neuropsychological 
tests. Finally, in order to evaluate white and grey matter integrity, participants underwent MRI 
using lesion-load analysis, voxel-based morphometry (VBM), and diffusion tensor imaging 
(DTI) (Prakash et al., 2010). Briefly, there were significant differences in aerobic capacity, 
measures of cognitive processing speed, and MRI outcomes between persons with MS and 
healthy controls (i.e., Cohen’s d > 0.67). In the MS subsample, higher aerobic capacity was 
associated with better performance on a composite measure of cognitive processing speed, but 
not on tests of learning and memory. This is consistent with results from the previous cross-
sectional study of fitness and cognition in MS (Prakash et al., 2007). A novel result from this 
study was that in the MS subsample, higher aerobic capacity was associated with less lesion-load 
volume, greater grey matter volume, and greater white matter integrity (i.e., greater fractional 
anisotropy in the left posterior thalamic radiation and right anterior corona radiata; Prakash et al., 
2010). The collective results from that study suggest that aerobic capacity, cognitive processing 
speed, and brain measures of white and grey matter integrity are interrelated in persons with mild 
MS disability (Prakash et al., 2010).  
The third, more recent cross-sectional study examined the relationships among multiple 
domains of physical fitness (e.g., aerobic capacity, muscle strength asymmetry, and balance) and 
cognitive processing speed in 31 persons with mild MS disability (median Patient-Determined 
Disease Steps (PDDS) score = 2) and 31 controls matched by age, sex, height, and weight 
(Sandroff & Motl, 2012). Aerobic capacity was measured as peak oxygen consumption (VO2peak) 
using an incremental exercise test to exhaustion on a cycle ergometer; lower limb muscle 
strength asymmetry (i.e., relative difference in the strength of a particular muscle group between 
strong and weak limbs) was measured using an isokinetic dynamometer; balance was measured 
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using static posturography. Cognitive processing speed was expressed as a composite z-score 
based on performance on the SDMT and PASAT (Sandroff & Motl, 2012). Briefly, there were 
significant differences in measures of fitness and cognition between persons with MS and 
matched controls that were moderate-to-large in magnitude. In the MS subsample, worse aerobic 
capacity (r = .44), worse balance (i.e., larger postural sway area) (r = −.52), and greater knee 
extensor asymmetry (r = −.39) were significantly associated with slower cognitive processing 
speed. Additional noteworthy results from that study were that those three domains of fitness 
accounted for differences in cognitive processing speed between persons with MS and controls, 
and explained a statistically significant amount of variance in cognitive processing speed (R
2 
= 
.39) in the MS subsample (Sandroff & Motl, 2012). 
Collectively, the cross-sectional results from studies of physical fitness and cognition in 
MS seemingly indicate that physical fitness is associated with cognitive processing speed, but 
not learning and memory in persons with mild MS disability. This suggests that enhancing 
aerobic capacity, balance, and muscular strength might represent avenues for improving slowed 
cognitive processing speed in this population. Importantly, results from cross-sectional studies of 
fitness and cognition, described above, are not consistent with the null results from previous 
RCTs of exercise training and cognition in MS. Despite the null results of the early RCTs, the 
cross-sectional research on fitness and cognition seems to suggest potential benefits of aerobic 
exercise, and perhaps resistance and balance exercise, on cognitive processing speed in persons 
with MS.  
One recent RCT recognized the importance of physical fitness and examined the effects 
of a supervised, aerobic exercise training intervention on fitness and cognitive function in 42 
persons with progressive MS who had moderate disability (mean EDSS = 4.95; Briken et al., 
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2014). Participants were randomized to one of three aerobic exercise training conditions (i.e., 
arm ergometry, rowing, cycle ergometry) or a wait-list control condition. All participants 
underwent an incremental exercise test to exhaustion to determine cardiorespiratory fitness at 
baseline and again at follow-up. Further, all participants underwent a battery of 
neuropsychological tests for measuring cognitive processing speed, verbal learning and memory, 
attention, and executive function at baseline and follow-up. The exercise training sessions took 
place 2-3 times per week for 15-45 minutes per session over 8-10 weeks; the exercise intensities 
per session were prescribed based on percentage of aerobic threshold demonstrated during the 
baseline incremental exercise test (Briken et al., 2014). 
Persons who underwent cycle ergometer training, but not rowing training, arm ergometer 
training, or wait-list control conditions demonstrated significant improvements in 
cardiorespiratory fitness. Those who underwent cycle ergometer training further demonstrated 
concomitant improvements in verbal memory and alertness, but not in cognitive processing 
speed or executive function, compared with the wait-list control group. Those changes in fitness 
explained ~16% of variance in changes in verbal memory and alertness within the cycle 
ergometry condition (Briken et al., 2014).  
The results from the recent exercise training RCT are promising, as that study reported 
improvements in physical fitness following the cycle ergometer training, along with significant 
improvements in verbal learning and memory in persons with progressive MS and moderate 
disability. This further has been replicated in a case study involving two memory-impaired 
persons with MS (Leavitt et al., 2014). However, those results still were not in-line with those 
from cross-sectional studies of fitness and cognition in MS, such that there were not 
improvements in cognitive processing speed following either exercise training intervention. This 
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might be attributable to disability status, as the sample from the recent RCT had substantially 
worse disability compared with the cross-sectional samples. Indeed, there have been two 
published studies on physical activity behavior and cognitive processing speed in persons with 
MS that have examined disability as a potential moderating factor of the physical 
activity/cognition relationship (Sandroff et al., 2013; 2014). 
One prospective study examined physical activity and cognition in 78 persons with mild 
and moderate MS disability (Sandroff et al., 2013). At baseline, physical activity was measured 
objectively using accelerometers, and was expressed as steps/day. After a six-month period 
without intervention, participants underwent neuropsychological assessments of cognitive 
processing speed, consisting of both oral and written versions of the SDMT, and the PASAT 
(Sandroff et al., 2013). After controlling for age, sex, and self-reported disability status in the 
overall sample, steps/day was significantly associated with cognitive processing speed based on 
oral and written SDMT scores (prs = .25-.29); steps/day was not significantly associated with 
performance on the PASAT (prs = .12). Importantly, the researchers split the overall sample into 
two groups of mild and moderate disability based on scores from a self-reported EDSS (SR-
EDSS) in order to examine the role of disability status as a potential moderator of the association 
between steps/day and cognitive processing speed. After controlling for age, steps/day was 
associated with cognitive processing speed (based on oral and written SDMT scores) in persons 
with mild (SR-EDSS < 4.0; prs = .35-.36), but not moderate (SR-EDSS ≥ 4.0; prs = .24-.27) MS 
disability (Sandroff et al., 2013). 
Another study used a RCT design to examine the effects of a six-month, Internet-based 
behavioral physical activity intervention on cognition in 76 persons with mild and moderate MS 
disability (Sandroff et al., 2014). All participants completed the International Physical Activity 
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Questionnaire (IPAQ; a self-report measure of physical activity that is valid in persons with MS) 
and underwent the oral version of the SDMT at baseline and follow-up. Participants were 
randomized to either the physical activity intervention or wait-list control condition. The 
intervention condition involved visiting a study website that was based on social cognitive 
theory; wearing a pedometer, completing a log-book, and using computerized software for 
guiding goal-setting and attainment; and participating in one-on-one video chat sessions with a 
behavior-change coach (Sandroff et al., 2014).  
Following the six-month period, persons with mild disability (PDDS = 0-2) in the 
intervention condition reported large increases in physical activity (i.e., Cohen’s d = 1.63), 
whereas those with moderate disability (PDDS = 3-6) in the intervention condition reported a 
small increase in physical activity relative to baseline (Cohen’s d = 0.24). The most important 
result from this study was that persons who underwent the intervention condition with mild MS 
disability demonstrated a clinically meaningful improvement in SDMT scores (~6 point 
increase), whereas those with moderate MS disability who underwent the intervention condition 
demonstrated minimal change (~1 point decrease) in SDMT scores. There were no changes in 
physical activity or cognitive processing speed over the six-month period for those who were 
randomized to the wait-list control condition. Further, among persons in the intervention 
condition, changes in average steps/day from the pedometer (i.e., objectively-measured physical 
activity) were associated with changes in SDMT scores in persons with mild (ρ = .52), but not 
moderate (ρ = .09) MS disability (Sandroff et al., 2014).  
 Following the publication of the poorly-designed early RCTs (i.e., Oken et al., 2004; 
Romberg et al., 2005), there seems to be an emerging pattern of results from cross-sectional 
studies of fitness, a recent RCT involving exercise training, and studies of physical activity and 
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cognitive function. That pattern of results suggests that different domains of exercise training and 
fitness might be associated with different domains of cognitive function. Those associations 
further might depend on disability status. To clarify that previous research, we recently 
completed a cross-sectional study that directly examined multiple domains of physical fitness 
(i.e., aerobic capacity (cardiorespiratory fitness) and muscular strength) and multiple domains of 
cognition (i.e., cognitive processing speed and learning and memory) in a relatively large sample 
of persons with mild, moderate, and severe MS disability (i.e., N=62) (Sandroff et al., 2015b). 
Briefly, aerobic capacity was measured as VO2peak from an incremental exercise test to 
exhaustion on a recumbent stepper, and lower limb muscle strength was expressed as peak 
torque of knee extensors and flexors, as well as asymmetry scores based on a maximal isometric 
muscle strength protocol on an isokinetic dynamometer. Participants also underwent the Brief 
International Cognitive Assessment in Multiple Sclerosis (BICAMS) neuropsychological battery, 
which consists of the oral version of the SDMT as a measure of cognitive processing speed, the 
California Verbal Learning Test-2 (CVLT-2) as a measure of verbal learning and memory, and 
the Brief Visuospatial Memory Test-Revised (BVMT-R) as a measure of visual learning and 
memory (Sandroff et al., 2015b).  
In the overall sample, measures of aerobic capacity and lower-limb muscle strength were 
associated with cognitive processing speed (r = .35-.41), but not learning and memory (r < .19). 
Similar to our previous examinations of physical activity and cognition (Sandroff et al., 2013; 
2014), disability status moderated those associations such that aerobic capacity and muscle 
strength were associated with cognitive processing speed in persons with mild (EDSS 0-3.5; r = 
.39-.53), but not moderate (EDSS 4.0-5.5) or severe (EDSS 6.0-6.5) MS disability (r < .21) 
(Sandroff et al., 2015b). Further, a post-hoc stepwise linear regression analysis indicated that 
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aerobic capacity, but not muscular strength outcomes, independently explained a statistically 
significant portion of variance (i.e., 17%) in SDMT scores. Results from this study provided 
direct, preliminary evidence of a selective association of physical fitness and cognitive function 
domains in persons with MS. Namely, cardiorespiratory fitness, and to a lesser extent lower limb 
muscle strength, is associated with the specific domain of cognitive processing speed, 
particularly among those with mild disability. This supports the design and implementation of an 
aerobic exercise training intervention for improving cognitive processing speed, but not learning 
and memory, in persons with mild MS disability. 
Overall, the research examining exercise training, fitness, physical activity and cognition 
in MS is clearly in its infancy. The disappointing results from early training studies, along with 
the growing pattern of results from recent studies of exercise, fitness, physical activity, and 
cognition in MS highlight the importance of considering the well-established literature in the 
general population across the lifespan (Hillman et al., 2008) as well as preliminary evidence 
from other neurological populations (McDonnell et al., 2011) as a way of better informing 
examinations of exercise training and cognition in MS. 
 
EXERCISE TRAINING AND COGNITION IN OTHER POPULATIONS 
There is a wealth of evidence describing robust effects of exercise training on cognitive 
functioning in the general population across the lifespan (i.e., children, younger adults, and older 
adults) (Voss, Nagamatsu, Liu-Ambrose, & Kramer, 2011). There further is preliminary 
evidence regarding the beneficial effects of exercise on cognitive function in persons with 
neurological disorders (i.e., schizophrenia, stroke, TBI), though the number of RCTs in those 
populations is substantially smaller than in healthy children, younger adults, and older adults. To 
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that end, this section of the review highlights meta-analyses, reviews, and exemplar RCTs to 
describe the overall effects of exercise training on cognition in healthy children, younger adults, 
and older adults, given the large body of literature. Given the lack of meta-analyses on the effects 
of exercise training on cognition in persons with neurological disorders, this section of the 
review primarily highlights RCT results in those populations. The acute effects of exercise on 
cognition in the general population are not discussed in this section, but rather, in the following 
section. The literature involving exercise training and cognitive functioning in healthy children, 
younger adults, older adults, respectively, as well as in persons with neurological disorders, 
provides a backdrop for informing the development of a well-designed RCT of exercise training 
on cognition in persons with MS. 
Exercise and Cognition in Children 
There has been increasing interest in the effects of exercise on cognition in children, 
though this relationship has primarily been studied in older adults, given the prevalence of 
cognitive impairment in those over 65 years of age. Compared with the gerontology literature, 
there are substantially fewer studies of exercise and cognition in children; however, the overall 
effects of physical activity on cognitive function in this population have been previously 
summarized. One early meta-analysis examined 125 effect sizes from 44 studies and reported 
that physical activity was associated with improved cognitive performance in children, with an 
overall effect size of 0.32 standard deviations (Sibley & Etnier, 2003). Importantly, the type of 
cognitive assessment emerged as a significant moderator variable, with the largest effects 
occurring for tests of perceptual skills (ES = 0.49) and the smallest effects for tests of memory 
(ES = 0.03). Age group was another moderator of the physical activity/cognition association with 
larger effects occurring in young elementary-school aged children (ES = 0.48) and middle-school 
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aged children (ES = 0.48) (Sibley & Etnier, 2003). A third noteworthy result from this meta-
analysis was that the authors identified a lack of true RCTs (at the time of publication) that could 
better support a causal association of exercise and cognition in children (Sibley & Etnier, 2003).  
Since the publication of that pivotal meta-analysis, there have been several well-designed 
RCTs that have reported improvements in executive control, in particular, in response to an 
exercise training intervention (e.g., Davis et al., 2007) that have been summarized in a review 
(Best, 2010). A more recent RCT (i.e., published after the Best review) examined the effect of a 
9-month long exercise intervention (i.e., the FITKids intervention) on executive control in 23 8- 
and 9-year old children (Chaddock-Heyman et al., 2013). Children were randomized to either an 
exercise intervention condition or wait-list control condition. The exercise intervention involved 
120 minutes per day of moderate-to-vigorous physical activity based on non-competitive games 
and aerobic fitness activities, for 5 days per week. Executive control was measured prior to and 
following the 9-month period based on outcomes on the modified flanker task. Following the 9-
month period, children randomized to the exercise intervention demonstrated improvements in 
executive control based on percent accuracy on incongruent trials of a modified flanker task 
relative to children randomized to the wait-list control condition (Chaddock-Heyman et al., 
2013). Importantly, at follow-up, children who participated in the intervention demonstrated 
accuracy rates similar to those of healthy young adults (Chaddock-Heyman et al., 2013). This 
study provides an example of how a well-designed exercise stimulus can selectively improve 
executive control in children. Of note, other recent investigations have reported improvements in 
memory and concomitant improvements in brain structure and function (e.g., Monti, Hillman, & 
Cohen, 2012; Chaddock et al, 2010) following the FITKids intervention. 
Exercise Training and Cognition in Healthy Adults 
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There is a relative paucity of literature directly examining exercise training on cognition 
in healthy younger adults, compared with the respective bodies of literature on children and older 
adults. This might be due to cognitive performance peaking during younger adulthood, 
presumably minimizing the potential for improvements in cognitive functioning following 
exercise (Hillman et al., 2008). Rather, younger adults tend to comprise control comparison 
groups in studies primarily examining exercise training and cognition in older adults. To date, 
there is not meta-analytic evidence to describe the overall effects of exercise training on 
cognition in younger adults only; however, one recent meta-analysis summarized the effects of 
exercise training on cognition in adults over 18 years of age (Smith et al., 2010). This meta-
analysis examined 234 effect sizes from 29 different studies involving both younger and older 
adults, and reported overall modest effects of aerobic exercise training on attention/processing 
speed (g = 0.16) and executive function (g = 0.12) (Smith et al., 2010). Although this meta-
analysis did include a substantial number of studies involving older adults, age was not a 
significant moderator of the associations among exercise training, attention/processing speed, 
and executive function (Smith et al., 2010). This seemingly indicates that across the span of 
adulthood, exercise training is similarly associated with improvements in attention/processing 
speed and executive function. 
Despite the lack of a meta-analysis to quantify the overall effects of exercise training on 
cognitive function in only younger adults, several longitudinal studies have examined those 
effects specifically within this age group. One longitudinal study reported statistically significant 
improvements in verbal learning and concomitant increases in cerebral blood volume in the 
hippocampus (i.e., dentate gyrus) following 12 weeks of aerobic exercise training in 11 healthy, 
but low-fit adults (age range: 21-45) (Pereira et al., 2007). One prospective study examined 
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whether changes in cardiorespiratory fitness from age 15 to 18 predicted cognitive functioning at 
age 18 in over 1 million Swedish young adults (Åberg et al., 2009). Importantly, improvements 
in cardiorespiratory fitness over 3-years were associated with increased global intelligence 
compared with those whose cardiorespiratory fitness worsened over that timespan (Åberg et al., 
2009). Another recent study examined the effects of aerobic exercise training on cognitive 
function (i.e., face-name matching task and Stroop color-word interference task performance) in 
47 healthy male students using a RCT design (Griffin, Mullally, Foley, Warmington, O’Mara, & 
Kelly, 2011). Participants were randomized to an exercise training intervention or sedentary 
control condition. The aerobic exercise condition consisted of 3 or 5 weeks of 60 minutes of 
aerobic cycling exercise that was performed at an intensity of 60% VO2max per session (Griffin et 
al., 2011). Importantly, persons undertaking 5 weeks of aerobic exercise demonstrated 
significantly better face-name matching performance compared with those in the control 
condition; there were no effects of exercise on Stroop performance (Griffin et al., 2011). This 
study provides an example of exercise training improving memory functions in healthy younger 
adults. However, given the overall dearth of exercise training RCTs on cognition within this 
population, compared with children and older adults, those results might not be broadly 
generalizable. 
Exercise Training and Cognition in Healthy Older Adults 
There is a large body of literature that documents robust, beneficial effects of exercise 
training on cognitive function in older adults (i.e., adults over 65 years of age). Early exercise 
training interventions reported that older adults, following participation in an exercise program, 
demonstrated improvements in physical fitness and better performance on cognitive tasks 
compared with controls (e.g., Dustman et al., 1984; Hawkins, Kramer, & Capaldi, 1992). For 
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example, a classic RCT examined the effect of a six-month long aerobic exercise intervention on 
executive control, based on performance on several tasks of executive control (i.e., task-
switching test, flanker task, stop-signal task) in 124 sedentary older adults (age range 60-75) 
(Kramer et al., 1999). Participants were randomized to either the aerobic exercise intervention 
condition (i.e., walking) or a stretching-and-toning control condition. Importantly, all 
participants underwent a maximal exercise test and the three executive control tests at baseline 
and follow-up to measure changes in cardiorespiratory fitness and cognition, respectively, over 
the six-month period (Kramer et al., 1999). Those in the intervention condition demonstrated a 
5.1% improvement in cardiorespiratory fitness, whereas those in the control condition 
demonstrated small decreases (i.e., -2.8%) in cardiorespiratory fitness. Further, those in the 
intervention condition demonstrated significant improvements in executive control based on 
better performance on the task-switching, flanker, and stop-signal tasks, particularly for 
conditions that required greater levels of executive control, relative to those in the control 
condition at follow-up (Kramer et al., 1999). Those results seemingly indicated that exercise 
might have a selective benefit on executive control processes in older adults. Selective 
improvements in executive control have since been replicated in a number of well-designed 
exercise training interventions involving older adults. The selective effects of exercise training 
on executive control have more recently been accompanied by concomitant changes in brain 
structure and function in this population (Voss et al., 2011).  
The overall effects of exercise training on cognition in older adults have been 
summarized by several meta-analyses (e.g., Colcombe & Kramer, 2003; Heyn, Abreu, & 
Ottenbacher, 2004). One seminal meta-analysis examined 18 studies that yielded 197 effect 
sizes, and reported that exercise training in healthy older adults was associated with overall 
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better performance on cognitive tasks with an average effect size of 0.48 standard deviations 
(Colcombe & Kramer, 2003). This meta-analysis confirmed the selective benefit of exercise 
training on cognition, such that the largest beneficial effects of exercise occurred for executive 
control processes (g = 0.68) compared with other cognitive processes (Colcombe & Kramer, 
2003). Interestingly, the moderator analysis indicated that combined exercise training (both 
strength and aerobic training) was associated with greater improvements in cognition than 
aerobic training alone (i.e., g = 0.59 vs. 0.41, respectively) (Colcombe & Kramer, 2003).  
Another meta-analysis examined 30 studies that yielded 85 effect sizes and reported that exercise 
training (consisting of a variety of aerobic, strength, and mobility-related exercises) was 
associated with improved cognitive performance in older adults with documented cognitive 
impairment, with an average effect size of 0.57 standard deviations (Heyn et al., 2004). That 
meta-analysis did not report a moderator analysis to determine whether exercise training had a 
selective effect on specific cognitive domains in older adults with documented cognitive 
impairment.  
The large body of literature in the general population, across the lifespan, indicates that 
exercise training might benefit cognition, particularly executive control processes, in healthy 
children, younger adults, and older adults. This is critical for informing the development of 
exercise training studies for improving cognition in other populations. Based on the equivocal 
results from the exercise training studies on cognition in MS, it is important to examine whether 
the literature from other neurological populations supports exercise training for improving 
cognitive function. If so, this would provide support for the feasibility of such a trial in MS. 
Indeed, there is preliminary evidence that aerobic exercise training might be beneficial for 
improving cognitive function in persons with neurological disorders (McDonnell et al., 2011).  
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Exercise Training and Cognitive Function in Persons with Neurological Disorders 
 There is emerging evidence that exercise training might improve cognitive function in 
persons with schizophrenia. Schizophrenia is a psychiatric illness that might be linked to the 
dysfunction of dopamine and other neurotransmitters in the brain. This dysfunction results in the 
brain’s decreased capacity to respond to stimuli via its usual inhibitory mechanisms (Freedman, 
2003). Those changes in brain function typically manifest as auditory hallucinations and 
delusions, as well as cognitive dysfunction (i.e., deficits in sustained attention and impaired 
short-term verbal and visual memory, in particular) (Freedman, 2003).  
One recent RCT examined the effect of an aerobic exercise training intervention on 
learning, memory, and hippocampal volume (i.e., a brain area implicated in learning and memory 
processes) in persons with schizophrenia (Pajonk et al., 2011). Sixteen persons with 
schizophrenia were randomized to either a 12-week aerobic exercise intervention condition or 
12-week non-exercise control condition. The aerobic exercise training condition involved 30 
minutes of cycling exercise 3 times per week (intensity was based on heart rate associated with a 
blood-lactate level of 14-18 mg/dL derived from a baseline maximal exercise test), whereas the 
non-exercise control condition consisted of 30 minutes of foosball, 3 times per week. This study 
further included 8 healthy control participants, who were matched based on demographic, 
cognitive, and fitness characteristics to those with schizophrenia; control participants also 
completed the aerobic exercise intervention (Pajonk et al., 2011). All participants underwent a 
maximal exercise test to determine aerobic capacity, the Rey Auditory Verbal Learning Test to 
assess verbal learning and memory, and an MRI to determine hippocampal volume at baseline 
and follow-up. There was a significant interaction of group across time on Rey Auditory Verbal 
Learning Test scores, such that persons with schizophrenia who were randomized to the aerobic 
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exercise condition demonstrated significant improvements in verbal learning and memory 
relative to persons with schizophrenia randomized to the non-exercise control condition (η2 = 
0.26). Those with schizophrenia who underwent the aerobic exercise intervention demonstrated 
statistically significant increases in relative hippocampal volume (i.e., 12%) compared to those 
with schizophrenia who underwent the non-exercise control condition (i.e., 1% decrease in 
relative hippocampal volume). Among persons with schizophrenia randomized to the aerobic 
exercise intervention, changes in cardiorespiratory fitness were strongly associated with changes 
in hippocampal volume (r = .71) (Pajonk et al., 2011). The primary results from this study 
provide support for aerobic exercise training for improving cognitive function and brain structure 
in persons with schizophrenia. 
 There is emerging evidence that might support exercise training for improving cognitive 
functioning in persons with TBI (McDonnell et al., 2011). Typically, mild TBI involves short-
term cognitive dysfunction without the presentation of neuroimaging abnormalities (Fogelman & 
Zafonte, 2012). One recent review indicated that there is minimal evidence that definitively 
supports exercise training for improving cognitive function in persons with TBI. This is based on 
the largely heterogeneous expression of cognitive symptoms and the severity of injuries in 
persons with TBI (Fogelman & Zafonte, 2012). One promising longitudinal study examined the 
effects of exercise training on cognition in 13 persons with mild TBI (i.e., ambulatory, without 
severe cognitive impairment) using a 4-week virtual reality-based exercise stimulus (Grealy, 
Johnson, & Ruston, 1999). Participants exercised on a cycle ergometer equipped with a virtual 
reality screen that presented either a Caribbean island course, a countryside course, or a cross-
country snow course, and cycled at a moderate intensity (i.e., 10-12 on Borg RPE scale) for 25 
minutes per session, 3 times per week. Cognition was measured using a battery of 
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neuropsychological tests that included measures of processing speed, executive function, 
learning, and memory that was administered pre- and post-intervention (Grealy et al., 1999). 
Persons with TBI increased their cycling distance by approximately 2 miles over the 4-week 
intervention. That training effect was accompanied by statistically significant improvements in 
processing speed, verbal learning and memory, and visual learning and memory (Grealy et al., 
1999). However, one limitation of that study was the lack of non-virtual reality exercise, and 
non-exercise virtual reality comparison groups of persons with TBI. This could have provided 
stronger evidence to dissociate the effects of virtual reality from aerobic exercise on cognition in 
this population. 
 There further is preliminary evidence that supports aerobic exercise for improving 
cognitive function in persons with stroke (McDonnell et al., 2011). Upwards of 60% of persons 
with stroke demonstrate slowed information processing speed and executive dysfunction based 
on neuropsychological testing (Barker-Collo & Feigin, 2006). Recently, one pilot RCT examined 
the effects of an 8-week aerobic exercise intervention on information processing speed and 
executive function in 38 post-stroke survivors (Quaney et al., 2009). Participants were 
randomized to an exercise intervention condition that consisted of progressive cycle ergometry 
up to 70% HRmax, 3 times per week, or a home-based stretching and toning control condition. 
Information processing speed was measured using the Serial Reaction Time Test (SRTT) and 
executive function was measured using the Wisconsin Card Sorting Task, Stroop color-word 
interference task, and Trail-Making Tests A and B. All participants underwent a maximal 
exercise test to measure aerobic capacity, as well as the battery of neuropsychological tests at 
baseline and again at follow-up (Quaney et al., 2009). There was a statistically significant 
increase in aerobic capacity demonstrated by those randomized to the intervention condition, 
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compared with those randomized to the control condition, which supported the effectiveness of 
the exercise stimulus. Importantly, there was a large, statistically significant improvement in RT 
based on the SRTT in stroke survivors in the intervention group compared with stroke survivors 
in the control group (d = 0.91). There were not statistically significant improvements on any 
other neuropsychological test for those in the intervention group relative to those in the control 
group (Quaney et al., 2009). The authors attributed this latter result to classical 
neuropsychological testing perhaps lacking the sensitivity to detect exercise-related changes in 
neurocognitive performance in persons with stroke (Quaney et al., 2009). Of note, more complex 
measures of cognitive functioning (i.e., computerized neurocognitive measures of executive 
control) were not collected in this study to examine the potential general (i.e., effects on simple 
information processing speed) or selective (i.e., effects on inhibitory control/response inhibition) 
effects of exercise training on cognition, as described in older adults of the general population 
(e.g., Colcombe & Kramer, 2003). 
 A recent longitudinal study extended those results by examining the effects of a six-
month aerobic and resistance exercise training intervention on cognitive performance in 41 
persons with stroke (Marzolini, Oh, McIlroy, & Brooks, 2012). Participants underwent a once-
weekly exercise class for 90 minutes over a six-month period. The exercise class consisted of 
combined aerobic exercise (i.e., walking, cycle/arm ergometery) and resistance training (i.e., 
upper and lower extremity resistance exercises). Cognitive function was measured by the 
Montreal Cognitive Assessment—a neuropsychological battery that includes tests of executive 
function, attention, and learning and memory—pre- and post-intervention (Marzolini et al., 
2012). Following the six-month intervention, participants demonstrated improvements in aerobic 
capacity as well as muscular strength (p < .001). Further, participants demonstrated large, 
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statistically significant improvements on tests of executive function and attention (p < .03), but 
not learning and memory (p = .40) (Marzolini et al., 2012). This suggests that perhaps different 
modes of exercise training have differential effects on cognitive function in persons with stroke 
(Marzolini et al., 2012). 
 Recent evidence from persons with neurological disorders does seem to support the 
feasibility of a well-designed RCT for improving cognition in persons with MS, although the 
optimal exercise stimulus for such a trial is unknown. Importantly, the delineation of exercise 
stimuli for largely successful interventions across the lifespan in the general population (and to a 
lesser extent in persons with neurological disorders) is, in part, based on examinations of the 
effects of acute bouts of aerobic exercise on cognition (e.g., Tomporowski, 2003; Lambourne & 
Tomporowski, 2010; Chang et al., 2012). 
 
ACUTE EXERCISE AND COGNITION 
There is a growing body of literature examining the effects of single (i.e., acute) bouts of 
exercise on cognitive function in the general population across the lifespan. This paradigm is 
important for identifying the ideal modality and intensity of an exercise stimulus for improving 
cognitive function for inclusion in a training study. This is because presumably, the acute effects 
of exercise on cognitive functioning will be additive during chronic exercise training much like 
the cumulative benefits of single bouts of aerobic exercise on cardiorespiratory fitness (Haskell, 
1994). This section first highlights reviews and meta-analyses that have summarized the 
beneficial effects of acute bouts of exercise on cognition in the general population across the 
lifespan, and then reviews key exemplar studies involving successful paradigms for measuring 
cognition before and after acute bouts of exercise. Finally, this section describes a pilot study of 
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acute exercise on cognition in persons with MS that we recently completed to inform the 
development of the present study. 
  To date, the evidence describing the effects of acute exercise on cognitive function has 
been summarized in an initial comprehensive review (Tomporowski, 2003), and the overall 
effects have been quantified in two subsequent meta-analyses (Lambourne & Tomporowski, 
2010; Chang et al., 2012). The initial review grouped studies involving the acute effects of 
exercise on cognition into three different categories: (a) studies examining cognitive 
performance following maximal exercise testing; (b) studies examining exercise-induced arousal 
on cognitive performance (i.e., studies that used the Yerkes-Dodson Law as a framework); and 
(c) studies examining the effects of relatively long, submaximal aerobic bouts of exercise on 
cognition (Tomporowksi, 2003). Based on the experimental design of the current study, this 
section only discusses the results from that third grouping. Briefly, a majority of the reviewed 
studies, mostly involving healthy college students as participants, did report significant 
improvements in cognition following acute bouts of aerobic exercise (i.e., ~73%). However, a 
small minority of the studies included in this classification did not report positive associations 
between acute aerobic exercise and cognitive function (i.e., ~13%). Nevertheless, that review 
summarized that exercise, when performed as treadmill exercise or cycle ergometry, exerted a 
selective, beneficial effect on cognition, when performed at a moderate intensity for fewer than 
90 minutes (Tomporowski, 2003). The largest effects of acute aerobic exercise were for complex 
problem solving and executive functioning, in particular, with additional benefits on tasks 
involving speed of decision-making; that review then described that acute aerobic exercise did 
not seem to affect perceptual tasks (i.e., stimulus identification) (Tomporowski, 2003). 
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 The overall effects of acute exercise on cognition have been quantitatively summarized 
by two recent meta-analyses (Lambourne & Tomporowski, 2010; Chang et al., 2012). The first 
meta-analysis examined 40 total studies yielding 235 total effects involving the acute effects of 
aerobic exercise on cognitive functioning in healthy adults (Lambourne & Tomporowski, 2010). 
That meta-analysis separately examined the effects of aerobic exercise on cognition both during 
and following exercise. Each study that was included in the meta-analysis involved repeated-
measures, within-subjects designs.  
Overall, when cognitive performance was measured during acute aerobic exercise, there 
were small, negative effects on cognition (i.e., ∆ = −0.14); those effects were stronger (i.e., more 
negative) for processing speed tasks. This suggests that processing speed decreases during acute 
aerobic exercise in healthy adults. One moderator of the acute exercise/cognition association was 
the time at which cognitive performance was assessed during exercise. There were mostly 
negative effects on cognition when measured during the first 20 minutes of aerobic exercise, 
whereas there were mostly positive effects on cognition when measured after at least 20 minutes 
of aerobic exercise (Lambourne & Tomporowski, 2010). This suggests that cognitive 
performance seems to worsen during the first twenty minutes of an aerobic exercise bout, but is 
seemingly enhanced after this point (i.e., rebound effect). An additional moderator included the 
modality of aerobic exercise, with more positive effects occurring for cycle ergometry and more 
negative effects for treadmill exercise (Lambourne & Tomporowski, 2010). This meta-analysis 
did not examine the negative effects of treadmill exercise on cognitive function based on walking 
or running exercise. Of note, since the publication of that meta-analysis, there is evidence that 
suggests that cognitive performance might not change during acute aerobic exercise in 
preadolescent children (Drollette et al., 2012). 
48 
 
On the other hand, when cognition was measured following acute bouts of aerobic 
exercise, there were overall positive effects on cognitive functioning that were small in 
magnitude (i.e., ∆ = 0.20). One moderator of the acute exercise/cognition association (when 
cognition was measured after exercise) was the cognitive domain that was examined. When 
measuring cognitive performance following acute aerobic exercise, there were larger effects on 
learning and memory and smaller effects on processing speed tasks. In general, the effects of 
acute exercise on cognition were larger following cycle ergometry, and smaller following 
treadmill exercise (Lambourne & Tomporowski, 2010). 
 One limitation of that meta-analysis was the overall small number of studies and effects 
that were included, based on the overall lack of evidence for acute aerobic exercise on cognition 
at the time of publication (Chang et al., 2012). To that end, a more recent meta-analysis provided 
an updated summary of the effects of acute exercise (including both aerobic and resistance 
exercise) on cognition in the general population, across the lifespan. That meta-analysis 
examined 79 studies that yielded 1034 effects—a volume of literature that was substantially 
larger than the number of studies and effects included in the previous meta-analysis (Chang et 
al., 2012). An important advantage of the more recent meta-analysis is that it included both 
healthy persons and persons with physical and cognitive limitations (Chang et al., 2012). 
Consistent with the previous meta-analysis, the more recent meta-analysis assessed the overall 
effects of acute exercise on cognition separately based on the timing of the measurement of 
cognitive performance. The authors quantified the effects of exercise on cognition when 
measured (a) during exercise; (b) immediately following exercise (i.e., within 1 minute of 
exercise completion); and (c) after a delay period of at least 1 minute following exercise.  
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Overall, there were small, positive effects of acute exercise on cognition (i.e., g = 0.10) 
regardless of the timing of cognitive measurement. When cognition was measured during 
exercise, there were small, positive effects of acute exercise on cognitive functioning (g = 0.10). 
Importantly, that meta-analysis identified the largest effects of acute exercise on tasks of 
executive function during exercise (d = 0.26), as well as larger effects when cognition was 
measured after at least 20 minutes of exercise (Chang et al., 2012). This suggests that during an 
acute bout of exercise, executive function is seemingly enhanced, in particular, after at least 20 
minutes of exercise. This is not fully consistent with results from the previous meta-analysis 
(Lambourne & Tomporowski, 2010) describing largely negative effects on cognitive 
performance during acute exercise. 
When cognition was measured immediately after exercise, there too were small, positive 
effects of acute exercise on cognitive functioning (g = 0.11). When cognition was measured 
immediately after exercise, the largest effects were on the domains of attention (d = 0.42), 
crystallized intelligence (d = 0.27), and executive function (d = 0.19). This suggests that 
immediately following acute exercise, those cognitive functions are seemingly enhanced. 
Importantly, intensity of exercise was identified as a significant moderator when cognition was 
measured immediately following exercise, such that there were larger effects for light (d = 0.17) 
and moderate (d = 0.12) intensity exercise, but there were no effects identified for hard, very 
hard, or maximal intensity exercise (Chang et al., 2012). This suggests that cognitive 
performance is enhanced immediately following light and moderate intensity exercise, in 
particular. 
When cognition was measured after a delay following exercise, there were small, positive 
effects of acute exercise on cognitive functioning (g = 0.10). When cognition was measured after 
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a delay, the largest effects of acute exercise were for crystallized intelligence (d = 0.28) and 
executive functioning tasks (d = 0.17). This suggests that acute exercise seemingly benefits 
crystallized intelligence and executive functions after a delay period following an exercise bout. 
Exercise intensity was identified as a moderator when cognition was measured after a delay 
period, such that there were positive effects on cognition when exercise was performed at a light, 
moderate, hard, very hard, or maximal intensity (d  > 0.20). Interestingly, there was an apparent 
dose-response effect, such that the largest effects of acute exercise on cognition following a 
delay period were for the most intense exercise stimuli, whereas the smallest effects were for 
exercise stimuli that were performed at a very light intensity (Chang et al., 2012). 
 That meta-analysis also examined the overall effects of acute exercise on cognition across 
different age groups. Acute exercise was significantly associated with cognition in children (d = 
.17), younger adults (d = .07), middle-aged adults (d = .18), and older adults (d = .18), 
independent of the timing of cognitive assessment (Chang et al., 2012). Importantly, when 
examining cognitive domain as a moderator in the overall sample, there were significant effects 
of acute exercise on executive function tasks including Stroop color-word interference (d = 
0.25), digit-symbol substitution (d = 0.17), incompatible reaction time (d = 0.29), decision-
making (d = 0.30), and verbal fluency (d = 0.31). There further were large effects identified for 
visual short-term memory (d = 0.23) and free-recall (d = 0.49) (Chang et al., 2012).  
 Individual studies have demonstrated that complex neurocognitive tests of executive 
control (i.e., modified flanker and Go/No-Go tasks) are particularly sensitive to acute aerobic 
exercise, as highlighted in a comprehensive review paper (e.g., Hillman et al., 2008). Neither 
meta-analysis on the overall effects of acute exercise on cognition included those tests as a 
moderator, when examining the effects of acute aerobic exercise on executive functioning 
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(Lambourne & Tomporowski, 2010; Chang et al., 2012). However, another recent, but smaller 
meta-analysis that evaluated the effects of acute exercise on executive function task performance 
did examine task complexity as a moderator variable (McMorris & Hale, 2012). For example, 
the authors hypothesized that increasing task complexity (i.e., complex central executive tasks, 
including inhibitory control based on modified-flanker task performance) would be more 
sensitive to the acute effects of aerobic exercise than simpler recall/basic attention tasks. The 
results from that meta-analysis indicated that indeed, there were larger effects on complex central 
executive tasks (g = 0.77) versus simpler recall/attention tests (g = 0.31). Further, on complex 
central executive tasks, the largest effects of acute aerobic exercise seemed to be for measures of 
speed, rather than measures of accuracy in studies involving adults (McMorris & Hale, 2012).  
 To that end, the above meta-analysis alluded to several highly successful studies of the 
effects of acute bouts of aerobic exercise on executive control using the modified flanker and 
Go/No-Go paradigms in the general population, across the lifespan. For example, one study used 
a within-subjects design to examine the effects of 20 minutes of treadmill exercise and quiet rest 
on inhibitory control using a modified flanker task in 20 preadolescent children (Hillman, 
Pontifex, Raine, Castelli, Hall, & Kramer, 2009). Children completed a 20-minute treadmill 
exercise condition (performed at 60% of maximal HR) and a 20-minute quiet rest condition on 
separate testing sessions. Participants undertook the flanker task approximately 25 minutes 
following each condition; the order of treadmill exercise and quiet rest conditions was 
counterbalanced across participants. Children demonstrated statistically significantly higher 
accuracy on incongruent trials of the modified flanker task following acute treadmill exercise 
relative to quiet rest; this effect was large in magnitude (η2 = 0.21). There further were similar 
effects on interference control (i.e., the cost of interfering stimuli) on percent accuracy following 
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acute treadmill exercise (Hillman et al., 2009). There were no significant differences in RT based 
on congruency (i.e., incongruent vs. congruent trials) across sessions, though this null effect was 
expected, given that children are generally impulsive on such neurocognitive tests, whereby 
larger exercise effects are typically observed for accuracy outcomes over RT outcomes (e.g., 
Davidson, Amso, Anderson, & Diamond, 2006). That exemplar study supports the sensitivity of 
the modified flanker task in response to acute aerobic exercise. 
 Another study used a repeated-measures design to examine the effects of acute aerobic 
exercise and yoga on flanker task performance in 30 healthy female college students (Gothe et 
al., 2013). Participants underwent 20-minutes of treadmill exercise, performed at 60-70% of 
maximal HR, and 20-minutes of guided Hatha yoga on separate testing sessions; the order of 
conditions was counterbalanced across participants. Immediately following both exercise 
conditions, participants underwent a modified flanker task. Participants demonstrated statistically 
significantly higher response accuracy on incongruent trials following yoga exercise (i.e., 90.3%) 
compared with treadmill exercise (i.e., 83.4%); this effect was large in magnitude (η2 = .40) 
(Gothe et al., 2013). There were no significant effects on RT between conditions (η2 = .02). 
Although the results from that study deviate from the pattern of results that suggest that acute 
aerobic exercise affects measures of speed, rather than accuracy, on complex central executive 
tasks in adults (McMorris & Hale, 2012), this might indicate that different outcomes from the 
modified flanker task perhaps are sensitive to different modalities of acute exercise. 
 The Go/No-Go task has also been used as a measure of executive control (i.e., response 
inhibition) following acute aerobic exercise. For example, one study used a repeated-measures, 
within-subjects design to examine the effect of different intensities of cycling exercise on P300 
amplitude using the Go/No-Go task in 12 healthy adults (age 22-33) (Kamijo et al., 2004). The 
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P300 is a neuroelectric component (i.e., event-related potential; ERP) that reflects the allocation 
of attentional resources in response to a given stimulus. All participants underwent a quiet rest 
control condition as well as cycle ergometer exercise conditions that were performed at high 
(i.e., maximal), medium (i.e., 12-14 on the Borg RPE scale), and low (i.e., 7-9 on the Borg RPE 
scale) intensities, respectively. The mean exercise duration for each session was approximately 
18 minutes. Following each condition, participants immediately completed the Go/No-Go task 
while undergoing an ERP paradigm (i.e., electroencephalography measurement). For both Go 
and No-Go tasks, there were statistically significant differences in P300 amplitude based on 
exercise intensity (p < .05). P300 amplitude was largest following medium intensity exercise 
compared with high and low intensity exercise, respectively, and quiet rest (Kamijo et al., 2004). 
Results from this exemplar study suggest that the Go/No-Go task is a measure of executive 
control that might be sensitive to different intensities of acute aerobic exercise.  
 Importantly, we recently completed a pilot study (i.e., Project EXACT—Exercise and 
Cognitive Testing in MS) that examined the acute effects of different modalities of exercise on 
cognitive processing speed and executive control relative to a quiet rest control condition in 24 
persons with mild MS disability (median EDSS = 3.0) using a completely within-subjects, 
repeated measures design (Sandroff et al., 2015a). We measured cognitive processing speed 
using the SDMT and executive control using a modified flanker task. Importantly, Project 
EXACT represents the first effort to examine the acute effects of exercise on cognition in MS. 
That study further represents the first effort to extend the application of the modified flanker task 
as a neurocognitive measure of executive control in a study of exercise and cognition in MS. All 
participants completed 5 testing sessions in our laboratory that were each separated by 7 days. 
Participants initially completed a baseline session that consisted of repeated cognitive testing to 
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minimize potential practice effects during sessions 2-5. Sessions 2-5 consisted of 20 minutes of 
quiet rest, moderate intensity treadmill walking exercise (i.e., 60% heart rate reserve (HRR)), 
moderate intensity cycle ergometer exercise (i.e., 60% HRR), and guided yoga that was adapted 
for persons with MS. The order of exercise and rest sessions was randomized and 
counterbalanced across participants such that the sample size of 24 allowed for one complete 
replication of the exercise conditions to minimize potential order effects of exercise conditions 
on cognitive processing speed and executive control. To examine the acute effects of each 
condition on cognition, we administered the SDMT and modified flanker task immediately 
before and after each condition. We further applied alternate forms of the SDMT and flanker 
task, respectively, across sessions to minimize potential carry-over effects on cognitive 
performance. 
There were general pre-to-post improvements in RT (regardless of congruency), but not 
accuracy, on the modified flanker task for all three exercise modalities compared with quiet rest. 
Those effects were large in magnitude (all ηp
2
 > .24). Of note, there were additional, selective 
improvements in RT based on congruency (i.e., pre-to-post reductions in the cost of interfering 
stimuli; interference control) on the modified flanker task for treadmill walking (ηp
2
 = .17), but 
not cycle ergometry (ηp
2
 < .01) or guided yoga (ηp
2
 < .03), compared with quiet rest. There 
further were no effects identified for any of the exercise conditions relative to quiet rest for 
cognitive processing speed, based on SDMT scores, perhaps due to carry-over effects. The 
primary results from that pilot study seemingly support treadmill walking as the ideal modality 
of acute exercise for selectively improving executive control (i.e., interference control of RT) in 
persons with MS. However, the optimal intensity of treadmill walking exercise for selectively 
improving executive control in persons with MS is unknown. 
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THE PRESENT STUDY 
Prior to developing a RCT on the effects of treadmill walking exercise on executive 
control in MS, it is necessary to examine the dose-dependent effects of varying intensities of 
walking exercise on this cognitive function in MS (i.e., the present study). Coupled with the 
results of our previous pilot trial (Project EXACT), such an endeavor would then optimize the 
exercise stimulus for inclusion in a well-designed clinical trial of exercise training and cognition 
in mild MS by identifying the ideal intensity of treadmill walking exercise for improving 
executive control in this population. The current study examined the effects of twenty-minute 
bouts of light, moderate, and vigorous intensity treadmill walking exercise compared with a quiet 
rest control condition on two aspects of executive control (i.e., interference control and response 
inhibition) in persons with MS, using a within-subjects, repeated-measures design. 
Based on previous research using modified-flanker and Go/No-Go paradigms in healthy 
control subjects (Kamijo et al., 2004; Pontifex et al., 2013; Drollette et al., 2012), the primary 
hypothesis was that walking at a moderate intensity would exert the strongest acute effects on 
executive control compared with light and vigorous intensity walking, respectively. The 
secondary hypothesis was that those effects would be larger in cognitive tasks requiring greater 
levels of executive control (i.e., incongruent trials on the modified flanker task and No-Go task). 
This pilot study and our previous research provide important information regarding the optimal 
exercise stimulus for inclusion in a well-designed RCT for possibly improving executive control 
in MS. If successful, this line of research will ultimately provide clinicians and patients with 
better guidelines for using chronic exercise training as an approach for the management of 
cognitive impairment as a highly prevalent, poorly-managed, and life-altering symptom of MS. 
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Chapter 3—Methods 
Participants 
The procedure was approved by the University of Illinois at Urbana-Champaign 
Institutional Review Board, and all participants provided written informed consent. Prospective 
participants with MS were recruited from the local community using flyers, support group 
meetings, neurologists, and our database of previous MS participants. During the initial contact, 
the experimenter explained the general study protocol to prospective participants over telephone 
or e-mail. If the prospective participant expressed interest in the study, the experimenter 
undertook screening for inclusion criteria. The primary inclusion criteria involved: (a) being 
between 18-54 years of age; (b) a definite diagnosis of MS based on physician’s confirmation of 
MS and its clinical course based on accepted criteria (Lubin & Reingold, 1996; McDonald et al., 
2001; Poser et al., 1983); (c) being relapse-free over the past 30 days (i.e., relative neurologic 
stability); (d) being independently ambulatory (i.e., able to walk without an assistive device); (e) 
self-reported willingness and ability to walk on a motor-driven treadmill; (f) SDMT scores 
greater than 43 (i.e., no worse than 2 standard deviations below the normative score for healthy 
controls—this ensured that participants did not have severe cognitive impairment; Parmenter, 
Testa, Schretlen, Weinstock-Guttman, & Benedict, 2009); and (g) low risk for contraindications 
for maximal exercise testing based on a “no” response on all items of the Physical Activity 
Readiness Questionnaire (PAR-Q; Thomas, Reading, & Shephard, 1992) or a single “yes” 
response along with a physician’s approval. The PAR-Q contains seven, yes/no items regarding 
contraindications for exercise testing (e.g., existing heart condition or chest pain at rest or during 
exercise) and is a standard screening inventory for stratifying risk for maximal exercise testing. 
Forty-nine prospective MS participants were contacted, with 33 remaining interested after 
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phone/e-mail contact; those individuals subsequently underwent screening. Of those 33 
individuals, 3 did not qualify for the study based on having a recent relapse or reporting two 
“yes” responses on the PAR-Q. One additional participant was excluded based on a SDMT score 
of 39. Of those 29 participants who qualified based on inclusion criteria, 5 canceled their testing 
session citing lack of time. This resulted in a final sample size of 24 ambulatory participants with 
MS. The sample size allowed for one complete replication of the randomized, counterbalanced 
conditions to minimize potential order effects of exercise conditions on executive control. All 
participants were remunerated $100 following the completion of the study (i.e., $20 per session).  
Primary Measures 
Executive Control. This study measured executive control (e.g., inhibitory control) using 
a modified Eriksen flanker task (Eriksen & Eriksen, 1974) and a Go/No-Go task (Nosek & 
Banaji, 2000). There is evidence in healthy control subjects that both tests are highly sensitive to 
the acute effects of aerobic exercise (e.g., Hillman et al., 2009; Kamijo et al., 2004). Further, 
both tests have been used in NIH-funded trials of exercise on cognition (e.g., Chaddock-Heyman 
et al., 2013; Kamijo et al., 2012).  
The modified flanker task has been included in the NIH toolbox for cognition as the 
primary measure of inhibitory control (i.e., interference control) and attention (Slotkin et al., 
2012). This paradigm requires individuals to inhibit task-irrelevant information in order to 
correctly respond to a centrally presented target stimulus amid either congruent (<<<<<) or 
incongruent flanking stimuli (<<><<). Participants are required to press a left button on a 
keyboard (i.e., the ‘z’ key) if the target stimulus is pointing to the left and a right button on a 
keyboard (i.e., the ‘m’ key) if the target stimulus is pointing to the right, regardless of condition 
(i.e., congruent or incongruent). The stimuli consisted of 3 cm tall white arrows presented on a 
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black background with a jittered inter-trial interval (ITI) of 1100, 1300, or 1500 milliseconds 
(ms). Participants completed 1 block of 200 stimuli (100 congruent/100 incongruent, occurring 
with equal probability in a randomized order). Outcomes from the modified flanker task include 
mean percent accuracy and RT (ms) for congruent and incongruent trials, separately. Another 
outcome from the modified flanker task is interference control, which is calculated for percent 
accuracy as (percent accuracy on congruent trials – percent accuracy on incongruent trials) and 
for RT as (RT on incongruent trials – RT on congruent trials) to provide positive values for both 
measures. This further provides a measure of the cost of interfering stimuli on executive control. 
Total test time is approximately 5 minutes.  
The Go/No-Go task is an additional measure of inhibitory control (i.e., response 
inhibition) (Nosek & Banaji, 2000). The “Go” task requires participants to respond via button-
press on a keyboard (i.e., the ‘m’ key) to rare target stimuli (e.g., F, 20% probability) and 
withhold their response to frequent non-target stimuli (e.g., T, 80% probability), whereas the 
“No-Go” task requires participants to respond to frequent, non-target stimuli (e.g., T, 80% 
probability) and withhold their response to rare, target stimuli (e.g., F, 20% probability; Nosek & 
Banaji, 2000). The “No-Go” task, in particular, requires greater levels of inhibitory control to 
complete correctly. The stimuli consisted of 3 cm tall white letters (i.e., T or F) presented on a 
black background with a fixed duration of 150 ms and a jittered ITI of 1300, 1500, or 1700 ms. 
Participants completed 1 block of 125 stimuli for both “Go” and “No-Go” tasks. The primary 
outcome from the Go/No-Go task includes percent accuracy to rare target stimuli for both “Go” 
and “No-Go” tasks, though percent accuracy on the “No-Go” task is the outcome of interest for 
the current study (Kamijo et al., 2012). Total test time is approximately 10 minutes. Importantly, 
our previous research favors the use of repeated administration of computerized tests of 
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cognitive function before and after acute bouts of exercise over repeated administrations of 
paper-based neuropsychological tests (e.g., SDMT), based on an apparent carry-over effect 
(Sandroff et al., 2015a).  
Cardiorespiratory Fitness. Cardiorespiratory fitness, operationally defined as peak 
oxygen consumption (VO2peak), was measured using an incremental exercise test on an 
electronically-braked, computer-driven cycle ergometer (Lode BV, Groningen, The Netherlands) 
and a metabolic cart designed to collect and assess respiratory gases (TrueOne, ParvoMedics, 
Sandy, UT). This test was necessary for the precise prescription of exercise intensity in the 
subsequent acute sessions (i.e., measurement of peak heart rate (HR) and resting HR for 
calculating HR reserve). Participants undertook the incremental exercise test on a cycle 
ergometer as cycling overcomes safety issues such as foot drop and other signs of paresis that 
can make maximal exercise on a treadmill unsafe for persons with MS (White & Dressendorfer, 
2004; Motl & Fernhall, 2012). Participants were initially fitted to the cycle ergometer, given 
standardized and tape-recorded descriptions of the test procedures, and allowed to ask questions. 
Participants were then outfitted for the collection of expired gases and rested for 1 minute on the 
cycle for measurement of resting HR. This was followed by a 3 minute warm-up at an initial 
work rate of 0 Watts (W). The work rate continuously increased at a rate of 15 W·min
-1 
until the 
participant volitionally terminated the test. This test protocol is a validated protocol for use in 
individuals with MS (Motl & Fernhall, 2012). Oxygen consumption (VO2) and respiratory 
exchange ratio (RER) were measured every 20 seconds. HR (using a Polar heart rate monitor 
(Polar Electro Oy, Kempele, Finland)) and RPE were recorded every minute during the test. 
VO2peak was defined as the highest recorded VO2 value when two of three criteria are satisfied: 
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(1) RER ≥1.10; (2) HRpeak within 10 beats·min
-1
 of age-predicted maximum (i.e., ~1 SD); or (3) 
RPEpeak ≥17.  
Cognitive Processing Speed. The oral version of the SDMT was included as a measure of 
cognitive processing speed (Smith, 1982; Benedict et al., 2006b). This measure was not used to 
document the acute effects of varying intensities of treadmill walking exercise on cognition. 
Rather, participants were screened for severe cognitive impairment using this 
neuropsychological test. Scores under 44 (i.e., severe cognitive impairment; Parmenter et al., 
2009) resulted in exclusion from the study. The SDMT has been validated in persons with MS, 
and is widely recognized as the most sensitive measure of cognitive processing speed in this 
population (Benedict & Zivadinov, 2011). Briefly, participants were presented with a page 
showing symbols paired with single digit numbers in a key. The task was to voice correct 
numbers for unpaired symbols as rapidly as possible for 90 seconds. Responses were recorded by 
the examiner. The primary outcome measure was the number of correct responses provided in 90 
seconds (i.e., raw score; Benedict & Walton, 2012). SDMT scores further were used for 
describing the baseline cognitive status of the sample. 
Disability Status. All participants underwent a neurological exam by a Neurostatus-
certified examiner who generated Expanded Disability Status Scale (EDSS; Kurtzke, 1983) 
scores for describing the disability status of the sample. Participants with EDSS scores within the 
range of 0-4.0 were included in the study. 
Procedure 
The overall flow of testing is presented in Figure 1. Participants completed 5 testing 
sessions at the same time of day, separated by 1 week, and were asked to abstain from exercising 
for 12 hours before testing sessions.  
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Baseline Session. All participants provided written informed consent followed by 
completion of the SDMT. SDMT scores under 44 (i.e., severe cognitive impairment; Parmenter 
et al., 2009) resulted in exclusion from the study. Participants then completed a short 
demographics questionnaire and undertook the executive control tests in a quiet, sound-
dampened room. Prior to the initial administration of these tests, the experimenter read 
standardized instructions for successfully completing each test. Further, for each test, participants 
completed a practice trial consisting of 20 stimuli to ensure that they understood the test 
instructions and completed each test correctly. Following the practice trials, participants then 
completed the modified flanker and Go/No-Go tasks, respectively. Both cognitive tasks took 
approximately 15 minutes to complete. Next, a Neurostatus-certified assessor administered a 
brief neurological examination for generation of an EDSS score for describing the sample. 
Participants then undertook the incremental maximal exercise test on a cycle ergometer. This test 
provided a measure of cardiorespiratory fitness and oxygen consumption as a function of HR for 
subsequent and precise prescription of the exercise intensities for the remaining submaximal 
exercise sessions. Immediately following the exercise test, participants underwent a second 
administration of executive control measures. This repeated cognitive testing during the baseline 
session served to minimize possible practice effects during sessions 2-5.  
Sessions 2-5. Those sessions occurred in a completely within-subjects design and the 
order of sessions was randomized and counterbalanced. Participants initially undertook 10 
minutes of quiet rest, completed the modified flanker and Go/No-Go tasks while seated in a 
quiet, sound-dampened room in a comfortable chair in the laboratory, and then performed the 
assigned condition. Importantly, throughout the study, the modified flanker task was consistently 
administered prior to the Go/No-Go task. The control condition involved sitting quietly for 30 
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minutes in a comfortable chair; the three bouts of treadmill walking began with a 5 minute 
warm-up on the treadmill, then 20 minutes of walking at a speed and grade associated with either 
30% (light), 50% (moderate), or 70% (vigorous) HRR (ACSM, 2013) and a 5 minute cool-down. 
The treadmill speed was initially selected based on ACSM equation based on energy expenditure 
(ACSM, 2013), and the actual intensity was monitored and documented by HR and RPE. Upon 
completion of the control or exercise bouts, participants again sat in a comfortable chair and 
completed the modified flanker and Go/No-Go tasks within 5 minutes following the condition 
(i.e., when HR returned near resting levels). All participants were remunerated following the 
completion of the 5
th
 session. 
Data Analysis 
The data were initially examined for normality violations, outliers, and errors. The 
primary analytic model involved a 4 × 2 repeated-measures analysis of variance (ANOVA). This 
was performed on measures of executive control to examine the hypothesis of differential effects 
of varying intensities of treadmill walking exercise on measures of executive control compared 
with quiet rest. Separate 4 × 2 ANOVAs were performed on RT and accuracy measures from the 
modified flanker task for interference control, congruent trials, and incongruent trials, as well as 
on percent accuracy from the No-Go task. This was done to examine the hypothesis of larger 
acute exercise effects on cognitive tasks requiring greater levels of executive control. For all 4 × 
2 ANOVAs, condition (light, moderate, vigorous, and rest) and time (pre- and post-) were 
included as within-subjects factors. If statistically significant, the overall interactions were 
decomposed with follow-up ANOVAs and t-tests. Effect sizes are expressed as partial eta-
squared (ηp
2
), with values of .01, .06, and .14 interpreted as small, moderate, and large, 
respectively (Cohen, 1988). Effect sizes for change over time per exercise condition relative to 
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quiet rest further are expressed as Cohen’s d (i.e., change over time for individual exercise 
condition minus change over time for quiet rest, divided by pooled standard deviation), 
interpreted as small, moderate, and large based on criteria of 0.2, 0.5, and 0.8, respectively 
(Cohen, 1988).  
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Chapter 4—Results 
Participant Characteristics 
 Demographic and clinical characteristics of the sample are presented in Table 1. Briefly, 
the mean age of the sample was 40.2 years, and the sample was primarily female (95.8%). Most 
participants reported at least a partial college education (i.e., 87.5%), and were employed (i.e., 
83.3%). All participants had a relapsing-remitting clinical disease course; this was not an a priori 
inclusion criterion for study participation. The sample was characterized by a relatively mild MS 
disability status, based on a median EDSS score of 3.0 (range = 1.5-4.0) (e.g., Confavreux & 
Vukusic, 2006). Regarding baseline cognitive processing speed, the sample had a mean SDMT 
score of 63.1 (SD = 10.3). That value is 0.30 SD-units below the regression-based normative 
value (that controlled for age, sex, and education) for healthy controls (Parmenter et al., 2009) 
thereby indicating that our sample, on average, did not have slowed cognitive processing speed. 
However, five participants (i.e., 20.8%) did demonstrate impaired cognitive processing speed 
based on SDMT scores more than 1.5 SD-units below the regression-based normative value for 
healthy controls. All participants fulfilled at least 2 of the 3 criteria for determining VO2peak, and 
the mean aerobic capacity of the sample was 23.5 ml/kg/min (SD = 5.5); this value is similar to 
other samples of persons with mild MS disability (e.g., Sandroff et al., 2015b).  
Manipulation Check 
 Mean predicted 30% HRR value (i.e., light intensity) based on HR data from the 
incremental exercise test for the overall sample was 103.3 beats per minute (bpm; SD = 10.7). 
Mean actual peak HR for the light intensity condition was 104.9 bpm (SD = 10.0), and mean 
RPE for this condition was 9.7 (SD = 2.2) (i.e., between very light and fairly light perceived 
exertion). Mean predicted 50% HRR value (i.e., moderate intensity) based on HR data from the 
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incremental exercise test for the overall sample was 120.4 bpm (SD = 11.3). Mean actual peak 
HR for the moderate intensity condition was 121.2 bpm (SD = 11.7), and mean RPE for this 
condition was 12.5 (SD = 2.2) (i.e., somewhat hard perceived exertion). Finally, mean predicted 
70% HRR value (i.e., vigorous intensity) based on HR data from the incremental exercise test 
was 137.3 bpm (SD = 12.8). Mean actual peak HR for the vigorous intensity condition was 137.0 
bpm (SD = 14.5), and mean RPE for this condition was 15.2 (SD = 1.7) (i.e., hard perceived 
exertion). Collectively, this indicates that each intensity of treadmill walking exercise was 
performed within 1.5% of the prescribed %HRR, and that the 30%, 50%, and 70% HRR 
conditions were associated with light, moderate, and vigorous intensity exercise, respectively 
(ACSM, 2013).  
Modified Flanker Task—RT  
 Descriptive data for measures of RT from the modified flanker task based on condition, 
time, and congruency are presented in Table 2 and the summaries of the three separate 4 × 2 
ANOVAs on measures of RT are in Table 3. Values for RT on the modified flanker task further 
are consistent with those from our previous pilot study (Sandroff et al., 2015a). 
 Interference Control. The first 4 × 2 ANOVA indicated an overall large, statistically 
significant, condition × time interaction (F(3,69) = 4.27, p = .01, ηp
2 
= .16) on interference 
control of RT. Light (d = −0.63), moderate (d = −0.45), and vigorous (d = −0.63) intensity 
treadmill walking exercise were associated with a greater reduction in the cost of interfering 
stimuli on RT compared with quiet rest (Figure 2). There were non-statistically significant main 
effects of condition (F(3,69) = 0.43, p = .73, ηp
2 
= .02) and time (F(1,23) = 1.25, p = .28, ηp
2 
= 
.05) on interference control of RT. To decompose the statistically significant overall 4 × 2 
interaction on interference control of RT, a follow-up 3 × 2 repeated-measures ANOVA was 
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performed with condition (light, moderate, and vigorous) and time (pre- and post-) included as 
within-subjects factors. This follow-up ANOVA indicated a non-statistically significant 
condition × time interaction (F(2,46) = 0.88, p = .42, ηp
2 
= .04) on interference control of RT 
such that there were similar pre-to-post reductions in the cost of interfering stimuli on RT for 
light, moderate, and vigorous intensity treadmill walking exercise.   
 Congruent Trials.  The second 4 × 2 ANOVA indicated a non-statistically significant 
condition × time interaction (F(3,69) = 1.78, p = .16, ηp
2 
= .07) on RT on congruent trials of the 
modified flanker task. There were not statistically significant pre-to-post reductions in RT 
overall for light (d = −0.17), moderate (d = −0.26), and vigorous (d = −0.20) intensity treadmill 
walking exercise relative to quiet rest. There further were non-statistically significant main 
effects of condition (F(3,69) = 2.50, p = .07, ηp
2 
= .10) and time (F(1,23) = 4.07, p = .06, ηp
2 
= 
.15) on RT on congruent trials of the modified flanker task.  
Incongruent Trials.  The third 4 × 2 ANOVA indicated a large, statistically significant 
condition × time interaction (F(3,69) = 6.32, p < .01, ηp
2 
= .22) on RT on incongruent trials of the 
modified flanker task. There were substantial pre-to-post reductions in RT overall for light (d = 
−0.43), moderate (d = −0.44), and vigorous (d = −0.48) intensity treadmill walking exercise 
relative to quiet rest. There further was a statistically significant main effect of time (F(1,23) = 
4.54, p = .04, ηp
2 
= .17) on RT on incongruent trials of the modified flanker task, whereby there 
were pre-to-post reductions in RT, regardless of condition. There was a non-statistically 
significant main effect of condition (F(3,69) = 2.09, p = .11, ηp
2
 = .08) on RT on incongruent 
trials of the modified flanker task. Collectively, this indicates that light, moderate, and vigorous 
intensity treadmill walking exercise had larger beneficial effects on RT on aspects of the 
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modified flanker task that required greater levels of executive control (i.e., incongruent trials 
relative to congruent trials). 
Modified Flanker Task—Response Accuracy 
 Descriptive data for measures of response accuracy from the modified flanker task based 
on condition, time, and congruency are presented in Table 2 and the summaries of the three 
separate 4 × 2 ANOVAs on measures of response accuracy are in Table 4. Values for response 
accuracy on the modified flanker task further are consistent with those from our previous pilot 
study (Sandroff et al., 2015a). 
  Interference Control. The first 4 × 2 ANOVA indicated a non-statistically significant 
condition × time interaction (F(3,69) = 1.03, p = .38, ηp
2 
= .04) on interference control of 
response accuracy. There were not statistically significant pre-to-post reductions in the cost of 
interfering stimuli on percent accuracy overall for light (d = −0.40), moderate (d = −0.57), and 
vigorous (d = −0.12) intensity treadmill walking exercise relative to quiet rest (Figure 3). There 
further were non-statistically significant main effects of condition (F(3,69) = 0.22, p = .88, ηp
2 
= 
.01) and time (F(1,23) = 1.42, p = .25, ηp
2 
= .06) on interference control of response accuracy.  
 Congruent Trials.  The second 4 × 2 ANOVA indicated a non-statistically significant 
condition × time interaction (F(3,69) = 1.20, p = .32, ηp
2 
= .05) on response accuracy on 
congruent trials of the modified flanker task. There were not statistically significant pre-to-post 
improvements in percent accuracy overall for light (d = −0.32), moderate (d = −0.54), and 
vigorous (d = −0.45) intensity treadmill walking exercise relative to quiet rest. There further 
were non-statistically significant main effects of condition (F(3,69) = 1.01, p = .39, ηp
2 
= .04) and 
time (F(1,23) = 0.20, p = .66, ηp
2 
= .01) on response accuracy on congruent trials of the modified 
flanker task.  
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Incongruent Trials.  The third 4 × 2 ANOVA indicated a non-statistically significant 
condition × time interaction (F(3,69) = 0.85, p = .47, ηp
2 
= .04) on response accuracy on 
incongruent trials of the modified flanker task. There were not statistically significant pre-to-post 
improvements in percent accuracy overall for light (d = 0.03), moderate (d = −0.10), and 
vigorous (d = −0.28) intensity treadmill walking exercise relative to quiet rest. There further 
were non-statistically significant main effects of condition (F(3,69) = 0.43, p = .73, ηp
2 
= .02) and 
time (F(1,23) = 0.85, p = .37, ηp
2 
= .04) on accuracy on incongruent trials of the modified flanker 
task. Collectively, this indicates that light, moderate, and vigorous intensity treadmill walking 
exercise seemingly did not have beneficial effects on percent accuracy on the modified flanker 
task relative to quiet rest that further did not differ based on level of executive control (i.e., 
congruency).  
Go/No-Go Task—Response Accuracy 
 Descriptive data for measures of response accuracy from the Go/No-Go task based on 
condition and time are presented in Table 5. ANOVA was not performed on response accuracy 
for the Go task as this does not require high levels of executive control (i.e., response inhibition). 
There further was an apparent ceiling effect for the Go task, given that accuracies approached 
100% for all four conditions (Table 5). 
No-Go Task.  The 4 × 2 ANOVA indicated a non-statistically significant condition × time 
interaction (F(3,69) = 0.33, p = .81, ηp
2 
= .01) on percent accuracy on the No-Go task. There 
were not statistically significant pre-to-post improvements in percent accuracy overall for light (d 
= 0.24), moderate (d = 0.24), and vigorous (d = 0.20) intensity treadmill walking exercise 
relative to quiet rest (Figure 4). There further were non-statistically significant main effects of 
condition (F(3,69) = 0.63, p = .60, ηp
2 
= .03) and time (F(1,23) = 2.53, p = .13, ηp
2 
= .10) on 
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percent accuracy for the No-Go task. Collectively, this indicates that light, moderate, and 
vigorous intensity treadmill walking exercise seemingly did not have beneficial effects on 
response inhibition relative to quiet rest.  
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Chapter 5—Discussion 
 Results from previous RCTs of exercise training on cognition in persons with MS have 
been equivocal (Motl et al., 2011), perhaps due to incorrect exercise stimuli (i.e., modality and 
intensity of exercise). To that end, treadmill walking exercise has recently been suggested to be 
the modality of aerobic exercise that might exert the greatest beneficial effects on executive 
control in persons with MS (Sandroff et al., 2015a). The current study examined the dose-
dependent effects of varying intensities of acute bouts of treadmill walking exercise on executive 
control outcomes in 24 persons with relapsing-remitting MS as the next step for identifying the 
appropriate exercise stimulus for possibly improving executive control in this population. The 
primary novel results of the present study were: (a) light, moderate, and vigorous intensity 
treadmill walking exercise significantly and similarly reduced the cost of interfering stimuli on 
RT on the modified flanker task relative to quiet rest; (b) there were no effects of exercise 
intensity relative to quiet rest on accuracy outcomes from the modified flanker task; and (c) there 
further were no effects of exercise intensity relative to quiet rest on the No-Go task. Collectively, 
this suggests that light, moderate, and vigorous intensity treadmill walking exercise might be 
appropriate exercise stimuli for inclusion in an exercise training intervention for improving 
speed-related aspects of executive control (i.e., RT). Those exercise stimuli might be particularly 
beneficial for improving performance on tasks that require greater levels of executive control 
(i.e., incongruent trials) in ambulatory persons with mild MS. The current results further suggest 
that those exercise stimuli might not be efficacious for improving accuracy-related aspects of 
executive control, namely interference control of percent accuracy or response inhibition. 
 The current results are exciting in that they represent the next step in identifying the 
optimal exercise stimulus for inclusion in an exercise training RCT for improving executive 
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control in persons with MS. Light, moderate, and vigorous intensity treadmill walking exercise 
were identified as having similarly beneficial effects on interference control of RT relative to 
quiet rest; those effects were large in magnitude. This has important implications for the 
development of such a RCT from an exercise prescription perspective. The present results 
support the development of a classical exercise training intervention that enhances 
cardiorespiratory fitness. This intervention would progressively include light, moderate, and 
vigorous intensity treadmill walking exercise as exercise stimuli for improving cardiorespiratory 
fitness and interference control of RT. In general, to enhance cardiorespiratory fitness, such well-
established exercise training programs follow a three-stage model of exercise progression 
outlined by the ACSM (ACSM, 2013). The first stage of this model involves the initiation stage 
of aerobic exercise progression. This stage aims to prepare participants for more intense aerobic 
exercise (i.e., by accumulating small improvements in cardiorespiratory fitness) and develop an 
orthopedic tolerance for exercise stress (ACSM, 2013). For example, during the initiation stage, 
participants with poor cardiorespiratory fitness might exercise at light-to-moderate intensities 
(i.e., 30-50% HRR) for 15-30 minutes on 3-4 days per week for up to 4 weeks. Following this 
period, participants progress to the improvement stage. This stage provides a gradual increase in 
the overall aerobic exercise stimulus, whereby participants realize substantial improvements in 
cardiorespiratory fitness (ACSM, 2013). For example, during this stage, participants might 
exercise at moderate-to-vigorous intensities (i.e., 50-85% HRR) for 25-40 minutes on 3-5 days 
per week for up to 20 weeks. The final stage of exercise progression is the maintenance stage, 
which aims to maintain the levels of cardiorespiratory fitness that were developed during the 
improvement stage over the long-term (ACSM, 2013). This might involve exercising at vigorous 
intensity (i.e., 70-85% HRR) for 20-60 minutes on 3-5 days per week over time, depending on an 
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individual’s exercise goals. The present results are particularly exciting in that they suggest that 
throughout such an exercise training intervention, persons with MS would presumably 
accumulate small acute improvements in interference control of RT at all three stages of exercise 
progression, as cardiorespiratory fitness improves and is maintained over time. Indeed, recent 
cross-sectional data seemingly suggest that better cardiorespiratory fitness is associated with 
shorter RT on the modified flanker task in persons with MS, and that improving fitness might 
have the potential for persons with mild MS to improve performance on this task to the level of a 
healthy control (Sandroff, Hillman, & Motl, in press (b)).  
The current results further have important implications for the development of such a 
RCT from a compliance perspective. Given that all three intensities of treadmill walking exercise 
were associated with improved interference control of RT, persons with MS who are not 
accustomed to treadmill walking exercise or who have poor cardiorespiratory fitness might not 
have to engage in overly-intense exercise at the outset of exercise training in order to accumulate 
beneficial effects on executive control. Rather, the current results suggest that persons can begin 
such a program with bouts of light intensity exercise and still accumulate small acute 
improvements in interference control of RT. As comfortability with treadmill walking exercise 
and/or cardiorespiratory fitness improves, participants with MS can gradually engage in more 
intense bouts of exercise over time (i.e., exercise progression) while accumulating additional 
improvements in interference control of RT. To that end, this would presumably increase the 
likelihood of a participant complying with such an intervention, as the exercise progression (i.e., 
increases in intensity/duration) could be gradual while still optimally improving cognitive 
performance over time (ACSM, 2013). Finally, given that the largest acute exercise effects were 
on interference control of RT, such a RCT should consider examining the effects of treadmill 
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walking exercise training on brain structure and function in regions associated with interference 
control and cognitive processing speed (i.e., dorsolateral prefrontal cortex, thalamus) (e.g., 
Penner et al., 2003; Benedict et al., 2013) in persons with mild MS disability.  
 The current study replicates our previous work, which indicated that interference control 
of RT was improved following an acute bout of moderate intensity treadmill walking exercise 
relative to quiet rest in persons with MS (Sandroff et al., 2015a). The present results extend those 
previous results to include acute bouts of light and vigorous intensity treadmill walking exercise, 
in addition to moderate intensity treadmill walking exercise. Taken together, this indicates a 
generalized pre-to-post effect of varying treadmill walking exercise intensities on interference 
control of RT on the modified flanker task. The current study replicates the lack of pre-to-post 
improvements on percent accuracy on the modified flanker task following moderate intensity 
treadmill walking exercise relative to quiet rest in persons with mild MS disability (Sandroff et 
al., 2015a). The present results extend this lack of association to include light and vigorous 
intensity treadmill walking exercise, respectively. The lack of acute exercise effects on No-Go 
performance further is consistent with our previous work, as the primary outcome of the Go/No-
Go task (i.e., a neurocognitive measure of response inhibition) is response accuracy. 
Collectively, this suggests that treadmill walking exercise might selectively improve speed-
related aspects of interference control over accuracy-related aspects of this executive function 
and response inhibition. Such a pattern of results is similar to those from studies of acute 
exercise on cognition in adults of the general population, such that acute aerobic exercise has 
been found to improve speed-related aspects of executive control over accuracy-related aspects 
of executive control (McMorris & Hale, 2012). It is unlikely that the current pattern of results 
can be attributed to a speed-accuracy tradeoff (e.g., Salthouse, 1996), given that on the modified 
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flanker task, accuracy remained relatively unchanged following the exercise conditions, whereas 
RT decreased. 
 The primary hypothesis of the current study involved moderate intensity treadmill 
walking exercise exerting the greatest beneficial effects on executive control relative to quiet rest 
(i.e., inverted-U hypothesis/Yerkes-Dodson Law; Davey, 1973), based on previous acute 
exercise studies in the general population (e.g., Kamijo et al., 2004). The secondary hypothesis 
was that those effects would be largest in tasks requiring greater levels of executive control (i.e., 
incongruent trials/No-Go task). The present results were partially consistent with those 
hypotheses. Moderate intensity exercise did not exert the largest beneficial effects on executive 
control relative to quiet rest; rather, the acute effects of light, moderate, and vigorous intensity 
treadmill walking exercise on cognitive performance were not statistically different from one 
another. However, the effects were more pronounced for incongruent trials of the modified 
flanker task relative to congruent trials (i.e., interference control of RT), consistent with the 
secondary a priori hypothesis. In other words, the acute effects of treadmill walking exercise on 
executive control in persons with MS did not follow an inverted-U relationship (i.e., Yerkes-
Dodson Law; Davey, 1973) that might have been driven by arousal (i.e., exercise intensity) 
(McMorris & Hale, 2012; Kamijo et al., 2004). This model posits that light intensity acute 
exercise (i.e., low arousal) results in sub-optimal cognitive performance, moderate intensity 
acute exercise (i.e., optimal arousal) results in maximal cognitive performance, and vigorous 
intensity acute exercise (i.e., high arousal) results in neural noise and sub-optimal cognitive 
performance (McMorris, Sproule, Turner, & Hale, 2011). Indeed, there is meta-analytic evidence 
supporting this inverted-U relationship of acute exercise intensities and cognitive performance in 
the general population (McMorris et al., 2011). Alternatively, the current results seemingly 
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indicate a generalized effect of treadmill walking exercise on cognitive performance in persons 
with mild MS disability, such that exercise intensity did not selectively influence cognitive 
performance on tasks of executive control. 
 We have previously speculated that treadmill walking exercise is essentially an inhibitory 
control task, and requires more attentional resources than other modalities of exercise (e.g., 
stationary cycling) (Sandroff et al., 2015a). The present results suggest that perhaps walking on a 
treadmill across multiple exercise intensities requires similar attentional resources for persons 
with mild MS disability. For example, it is plausible that light, moderate, and vigorous intensity 
treadmill walking all require participants to selectively attend to important central information in 
the visual domain for balance and coordination, and to selectively inhibit non-essential 
peripheral information (e.g., details of room setup) in order to maintain safety. We further 
speculate that with chronic treadmill walking exercise, such acute reductions in the cost of 
interfering stimuli on RT would be additive and cumulative over time (i.e., compensation). 
However, the potential mechanisms for how chronic treadmill walking exercise improves 
cognition in MS have not been directly tested. Future research should consider examining 
cognitive performance during acute bouts of aerobic exercise in persons with MS to test the 
hypothesis of whether treadmill walking exercise actually requires more attentional resources 
than other exercise modalities, and whether or not this varies based on exercise intensity.  
 Of note, the current examination represents a pilot study to delineate the optimal intensity 
of treadmill walking exercise for inclusion in an exercise training RCT for improving executive 
control in persons with mild MS disability. We have previously acknowledged that this approach 
does not aim to directly treat MS-related cognitive dysfunction overall (Sandroff et al., 2015a). 
The current sample did not demonstrate impaired cognitive processing speed based on SDMT 
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scores that were 0.30 SD-units below regression-based normative value for healthy controls 
(Parmenter et al., 2009). SDMT scores have often been considered a proxy of generalized 
cognitive dysfunction in MS (Benedict & Zivadinov, 2011). This sample of persons with MS 
was intentionally recruited in order to ensure that participants understood the directions of the 
cognitive and exercise protocols. As such, the current results provide proof-of-principle data 
supporting light, moderate, and vigorous intensity treadmill walking exercise for improving 
interference control of RT in persons with MS without slowed cognitive processing speed. 
Nevertheless, this highlights the importance of ultimately tailoring the exercise and cognitive 
stimuli for future exercise training RCTs for those with marked executive dysfunction (i.e., 
developing rehabilitation interventions for those with the most need). Further, it is unknown if 
such a RCT could result in more generalized effects on cognition, as there is a possibility that 
chronic treadmill walking exercise might improve cognitive processing speed, learning and 
memory, or other executive functions in persons with MS. 
The current study involved a strong experimental design (i.e., within-subjects design, 
inclusion of a baseline session to minimize possible practice effects across conditions, 
randomization and counterbalancing of exercise intensities to minimize potential order effects), 
examination of multiple aspects of executive control (i.e., interference control and response 
inhibition) and continuation of a novel approach for delineating the optimal exercise stimulus (or 
stimuli) for improving executive control in persons with mild MS disability. However, there are 
several noteworthy limitations. As was the case with our previous research (Sandroff et al., 
2015a), although randomizing and counterbalancing the experimental conditions across 24 
persons with MS minimized the potential for order effects across sessions, it was not possible to 
entirely dismiss order effects as a potential explanation for the present results. This might have 
77 
 
been overcome by increasing the sample size and administering multiple randomized, 
counterbalanced orders of experimental conditions. As we previously observed (Sandroff et al., 
2015a), there may have been possible ceiling effects for accuracy on the modified flanker and 
No-Go tasks. Participants demonstrated accuracies over 90% for each exercise intensity for the 
modified flanker task, and accuracies approaching 90% for each exercise intensity for the No-Go 
task. Those high accuracy levels are consistent with those from other acute exercise studies that 
have used the modified flanker paradigm (e.g., Pontifex & Hillman, 2007), but are higher than 
those from studies that have used the Go/No-Go paradigm (e.g., Niewenhuis, Yeung, & Cohen, 
2004) in healthy adults of the general population. Perhaps the current MS sample implicitly 
prioritized accuracy over speed for both neurocognitive tasks, despite receiving explicit 
instructions to prioritize speed and accuracy equally (e.g., Sandroff, Benedict, & Motl, in press 
(a)). It is of note that there are no validity/reliability data on the modified flanker task as a 
neuropsychological measure of inhibitory control in MS; however, this task is highly reliable in 
older adults (Holtzer, Mahoney, & Verghese, 2014), and normative data are available for the 
general population in the NIH Toolbox scoring manual (Slotkin et al., 2012). The current sample 
only involved persons with relapsing-remitting MS, and the current results cannot be fully 
generalized to persons with progressive presentations of MS. The present results further are 
limited to those with relatively mild physical and cognitive MS disability who were able to walk 
on a motor-driven treadmill at vigorous intensity. This study involved persons with high levels of 
education (i.e., over 70% earned at least a college degree), and perhaps the results cannot be fully 
generalized to those with lower levels of education. Another limitation involves the lack of 
administration of a complete neuropsychological battery during the baseline session to better 
characterize the cognitive status of the sample. Finally, the current study did not control for 
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potential influences of age, sex, and disability status on the acute effects of varying intensities of 
treadmill walking exercise on executive control. The within-subjects, repeated-measures 
experimental design accounts for this, as participants serve as their own control, and variability 
among participants due to individual differences (i.e., age, sex, disability status) is completely 
removed from the error term (Stevens, 1996). 
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Chapter 6—Conclusions 
 There is evidence that treadmill walking exercise might be the modality of exercise that 
exerts the greatest beneficial effects on executive control in persons with mild MS disability. To 
that end, the current study is the first to examine the acute effects of varying intensities of 
treadmill walking exercise on multiple aspects of executive control in persons with mild MS 
disability. The present results support light, moderate, and vigorous intensity treadmill walking 
as exercise stimuli that might selectively benefit interference control of RT, but not accuracy-
related aspects of interference control or response inhibition. This represents the next step in 
delineating the optimal exercise stimuli (i.e., modality and intensity) for inclusion in a 
subsequent longitudinal exercise training intervention for improving this cognitive function in 
persons with mild MS disability. Such results are especially exciting as including those three 
treadmill walking exercise intensities for improving cognitive performance in such an 
intervention is also advantageous for improving cardiorespiratory fitness and participant 
compliance. Ultimately, further testing is necessary to elucidate potential mechanisms as to how 
chronic treadmill walking exercise improves cognition in this population and to tailor the 
exercise stimuli amongst cognitively impaired MS samples. 
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Chapter 7—Tables and Figures 
Table 1: Descriptive characteristics of 24 persons with MS. 
 
Variable MS (N=24) 
Age (years) 40.2 (8.7) 
Sex (n, % female) 23/24 (95.8%) 
Education (n, %) 
     High School  
     Some College 
     College/University Graduate 
 
3/24 (12.5%) 
4/24 (16.6%) 
17/24 (70.8%) 
Employment (n, % employed) 20/24 (83.3%) 
Clinical Disease Course (n, % RRMS) 24/24 (100%) 
Disease Duration (years) 8.1 (6.8) 
EDSS (median, range) 3.0 (1.5-4.0) 
SDMT (raw score) 63.1 (10.3) 
VO2peak (ml∙kg
-1∙min-1) 23.5 (5.5) 
Aerobic Exercise History (days/week) 3.0 (1.9) 
Note: All data presented as mean (SD) unless otherwise noted; RRMS=Relapsing-remitting 
multiple sclerosis; EDSS=Expanded Disability Status Scale; SDMT=Symbol Digit Modalities 
Test; VO2peak=Peak aerobic capacity. 
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Table 2: Measures of reaction time (RT) and response accuracy on a modified-flanker task 
based on condition, time, and congruency in 24 persons with MS. 
 
 Light Intensity 
Moderate 
Intensity 
Vigorous 
Intensity 
Quiet Rest 
Variable Pre- Post- Pre- Post- Pre- Post- Pre- Post- 
Congruent- 
RT (ms) 
412.0 
(7.5) 
406.9 
(8.5) 
410.9 
(6.9) 
402.5 
(9.4) 
407.3 
(8.6) 
400.2 
(8.5) 
412.2 
(9.3) 
414.0 
(10.0) 
Incongruent- 
RT (ms) 
463.7 
(10.1) 
451.9 
(10.2) 
460.4 
(8.7) 
450.0 
(10.8) 
460.5 
(9.5) 
447.2 
(9.9) 
459.4 
(10.4) 
469.2 
(11.3) 
IC-RT (ms) 
51.7 
(5.2) 
45.0 
(4.1) 
49.5 
(4.8) 
47.5 
(3.9) 
53.2 
(4.9) 
47.0 
(4.6) 
47.2 
(4.4) 
55.3 
(4.2) 
Congruent-
Accuracy (%) 
97.8 
(0.8) 
97.6 
(1.1) 
97.6 
(0.9) 
95.5 
(2.8) 
98.4 
(0.3) 
97.7 
(0.8) 
95.9 
(2.5) 
98.2 
(0.7) 
Incongruent-
Accuracy (%) 
92.6 
(2.5) 
94.3 
(2.2) 
92.9 
(2.2) 
93.0 
(2.3) 
94.7 
(1.0) 
93.4 
(2.2) 
92.7 
(2.7) 
94.0 
(1.6) 
IC-Accuracy 
(%) 
5.2 
(2.0) 
3.4 
(1.2) 
4.8 
(1.5) 
2.5 
(0.9) 
3.7 
(0.9) 
4.3 
(1.8) 
3.2 
(0.9) 
4.3 
(1.0) 
Note: All data presented as mean (SE); RT=Reaction time; ms=milliseconds; IC=Interference 
Control 
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Table 3: Summary of 4 × 2 repeated-measures ANOVAs for the acute effects of light, 
moderate, and vigorous treadmill walking exercise and quiet rest on reaction time (RT) on 
a modified flanker task in 24 persons with MS. 
 
 
Congruent Incongruent 
Interference 
Control 
F p ηp
2
 F p ηp
2
 F p ηp
2
 
Condition × Time 1.78 .16 .07 6.32 <.01* .22 4.27 .01* .16 
Condition 2.50 .07 .10 2.09 .11 .08 0.43 .73 .02 
Time 4.07 .06 .15 4.54 .04* .17 1.25 .28 .05 
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Table 4: Summary of 4 × 2 repeated-measures ANOVAs for the acute effects of light, 
moderate, and vigorous intensity treadmill walking exercise and quiet rest on percent 
accuracy on a modified flanker task in 24 persons with MS. 
 
 
Congruent Incongruent 
Interference 
Control 
F p ηp
2
 F p ηp
2
 F p ηp
2
 
Condition × Time 1.20 .32 .05 0.85 .47 .04 1.03 .38 .04 
Condition 1.01 .39 .04 0.43 .73 .02 0.22 .88 .01 
Time 0.20 .66 .01 0.85 .37 .04 1.42 .25 .06 
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Table 5: Measures of response accuracy on a Go/No-Go task based on condition and time 
in 24 persons with MS. 
 
 Light Intensity 
Moderate 
Intensity 
Vigorous 
Intensity 
Quiet Rest 
Variable Pre- Post- Pre- Post- Pre- Post- Pre- Post- 
Go Accuracy 
(%) 
100.0 
(0.0) 
99.8 
(0.2) 
100.0 
(0.0) 
100.0 
(0.0) 
100.0 
(0.0) 
100.0 
(0.0) 
99.5 
(0.3) 
100.0 
(0.0) 
No-Go 
Accuracy (%) 
88.4 
(2.5) 
87.8 
(2.2) 
88.0 
(1.8) 
87.2 
(2.4) 
89.4 
(1.9) 
88.2 
(1.9) 
88.7 
(2.0) 
85.6 
(2.9) 
Note: All data presented as mean (SE);  
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Figure 1: Flow of Testing. 
 
 
 
Initial Contact 
Description of Protocol, Screening, Scheduling 
Exclude: out of age range; no definite 
MS diagnosis; relapse in previous 30 
days; non-independently ambulatory 
(i.e., EDSS > 4.0); not willing/able to 
walk on treadmill; ≥ 2 “yes” responses 
on PAR-Q 
Session 1 (Baseline): 
1. Informed Consent 
2. SDMT 
3. Questionnaires 
4. Cognitive Testing  
5. EDSS 
6. Incremental Exercise Test 
7. Cognitive Testing  
 
Exclude: ≤ 43 on the SDMT 
Sessions 2-5: 
30% HRR 
 
1. Quiet Rest  
2. Cognitive Testing 
3. Treadmill Walking 
4. Cognitive Testing 
5. Payment* 
 
* = if Session 5 
Sessions 2-5: 
50% HRR 
 
1. Quiet Rest 
2. Cognitive Testing 
3. Treadmill Walking 
4. Cognitive Testing 
5. Payment* 
 
* = if Session 5 
 
Sessions 2-5: 
70% HRR 
 
1. Quiet Rest 
2. Cognitive Testing 
3. Treadmill Walking 
4. Cognitive Testing 
5. Payment* 
 
* = if Session 5 
 
Sessions 2-5: 
Quiet Rest 
 
1. Quiet Rest 
2. Cognitive Testing 
3. Quiet Rest 
4. Cognitive Testing 
5. Payment* 
 
* = if Session 5 
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Figure 2: Acute effects of light, moderate, and vigorous intensity treadmill walking exercise 
and quiet rest on interference control of reaction time (RT; i.e., RT on incongruent trials 
minus RT on congruent trials) on a modified flanker task, along with standard error bars 
in 24 persons with MS. 
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Figure 3: Acute effects of light, moderate, and vigorous intensity treadmill walking exercise 
and quiet rest on interference control of percent accuracy (i.e., accuracy on congruent 
trials minus accuracy on congruent trials) on a modified flanker task, along with standard 
error bars in 24 persons with MS. 
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Figure 4: Acute effects of light, moderate, and vigorous intensity treadmill walking exercise 
and quiet rest on percent accuracy on a No-Go task (i.e., response inhibition), along with 
standard error bars in 24 persons with MS. 
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